bcr_patient_uuid	patient_ID	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	pharmaceutical_therapy_drug_name	clinical_trial_drug_classification	pharmaceutical_therapy_type	days_to_drug_start	pharmaceutical_tx_ongoing_indicator	days_to_drug_end	treatment_best_response	days_to_stem_cell_transplantation	pharm_regimen	pharm_regimen_other	drug_cycles	pharma_type_other	drug_units	drug_tota_dose_units	drug_dose	regimen_number	drug_route	stem_cell_transplantation	stem_cell_transplantation_type	therapy_regimen	therapy_regimen_other	drug_total_dose	therapy_on_clinical_trial
1	92554413-9EBC-4354-8E1B-9682F3A031D9	TCGA.4N.A93T	TCGA-4N-A93T-D65957	25E5CD87-BB8D-4D2A-8219-1660D2F13AEE	2014-10-1	XELODA	NA	CHEMOTHERAPY	68	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6020	3aefce87-3734-4b5f-a4e2-c62dbba5badf	2011-1-11	STUDY DRUG AMG 655	NA	OTHER, SPECIFY IN NOTES	96	FALSE	270	NA	NA	NA	NA	12	PROTOCOL AMG 20060464	MG/KG	MG/KG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	NA	NA
3	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6049	891f0411-bdcc-468d-bc50-acc539d6bc11	2011-1-12	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	96	FALSE	270	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	8435	NA
4	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6091	75929a1b-da0b-4859-9592-e0b096b3e46c	2011-1-12	5 FU	NA	CHEMOTHERAPY	551	TRUE	NA	NA	NA	NA	NA	7	NA	MG	MG	725	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	5075	NA
5	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6025	b7b6c0f7-bf3f-45c3-b847-79b03842ba16	2011-1-12	AVASTIN	NA	TARGETED MOLECULAR THERAPY	96	FALSE	270	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	3620	NA
6	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6056	4c5e40d8-6a8a-4638-8b23-2461b1dcdd79	2011-1-12	AVASTIN	NA	TARGETED MOLECULAR THERAPY	551	TRUE	NA	NA	NA	NA	NA	7	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	2200	NA
7	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6046	c8f771fa-6176-48de-8426-1f572f7866d8	2011-1-12	OXALIPLATIN	NA	CHEMOTHERAPY	96	FALSE	186	NA	NA	NA	NA	7	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	985	NA
8	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6092	fdda207f-5b42-4d35-87bc-c3156b31312d	2011-1-12	5 FU	NA	CHEMOTHERAPY	551	TRUE	NA	NA	NA	NA	NA	7	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	30200	NA
9	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6059	dc9ad6a9-f324-4d56-93ae-dad6cd659a43	2011-1-12	IRINOTECAN	NA	CHEMOTHERAPY	551	TRUE	NA	NA	NA	NA	NA	7	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	2250	NA
10	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6051	25d52ff6-0b91-435d-8fc0-dcdc5519fa81	2011-1-12	5 FU	NA	CHEMOTHERAPY	96	FALSE	272	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	42950	NA
11	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D6055	409b319f-5642-4f38-8e5d-d948107d0425	2011-1-12	5 FU	NA	CHEMOTHERAPY	96	FALSE	270	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	7185	NA
12	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D12771	7c651876-aff7-4947-9797-98c908dd30e4	2011-6-7	5FU	NA	CHEMOTHERAPY	551	FALSE	756	NA	NA	NA	NA	13	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	56000	NA
13	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D12773	e0b656ab-0cd3-4cd5-84d9-919225e636f2	2011-6-7	AVASTIN	NA	TARGETED MOLECULAR THERAPY	551	FALSE	739	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	3775	NA
14	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D12772	6d5ce679-235e-463c-85a8-d6812506f399	2011-6-7	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	725	FALSE	754	NA	NA	NA	NA	3	ANCILLARY	MG	MG	500	2	INTRAVESICAL	NA	NA	PROGRESSION	NA	1500	NA
15	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D12770	9859896f-c740-4094-96ad-102b312c4b6b	2011-6-7	5 FU	NA	CHEMOTHERAPY	551	FALSE	754	NA	NA	NA	NA	13	NA	MG	MG	725	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	9425	NA
16	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D12768	2887faa4-89f4-40e5-ab43-8cbc7095ac80	2011-6-7	IRINOTECAN	NA	CHEMOTHERAPY	551	FALSE	711	NA	NA	NA	NA	9	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	2890	NA
17	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31097	3254ea81-298b-461f-9e51-2daa00fb9c60	2012-4-24	IRINOTECAN	NA	CHEMOTHERAPY	844	FALSE	984	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
18	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31177	28b4628d-26ff-4ffe-998d-3a1de2be56b8	2012-4-24	5-FU	NA	CHEMOTHERAPY	844	FALSE	844	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
19	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31178	9ef7c5d5-470f-4586-8ff2-adb6b1db8667	2012-4-24	LEUCOVORIN	NA	ANCILLARY	844	FALSE	844	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
20	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31179	0b9b3648-918f-4f14-a9c8-5cd58d935ed7	2012-4-24	5-FU	NA	CHEMOTHERAPY	844	FALSE	846	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
21	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31180	386e2918-33c5-4df0-a196-28864d9a87e3	2012-4-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	844	FALSE	984	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
22	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31182	b57bfe0a-f932-417b-b510-dc6c1800c1a7	2012-4-24	IRINOTECAN	NA	CHEMOTHERAPY	1041	FALSE	1105	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
23	565e2726-4942-4726-89d3-c5e3797f7204	TCGA.A6.2671	TCGA-A6-2671-D31184	f8603c4a-b9ed-4efa-a9d1-07b84ae5c330	2012-4-24	ERBITUX	NA	TARGETED MOLECULAR THERAPY	1041	FALSE	1091	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
24	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D4949	5022a88e-849c-499e-8708-80ef8f39165c	2010-10-15	5 FU	NA	CHEMOTHERAPY	75	FALSE	237	NA	NA	NA	NA	12	NA	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9150	NA
25	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D4948	b5b3adc2-ffb4-480a-866c-996bf91eed24	2010-10-15	LEVCOVORIN	NA	OTHER, SPECIFY IN NOTES	75	FALSE	237	NA	NA	NA	NA	12	ANCILLARY	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9150	NA
26	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D4947	365ae66b-f33f-45f3-8894-0ad421609e63	2010-10-15	OXALIPLATIN	NA	CHEMOTHERAPY	75	FALSE	237	NA	NA	NA	NA	12	NA	MG	MG	170	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1950	NA
27	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D4951	5a028017-d8ab-465a-8dca-6416332d59d8	2010-10-15	5 FU	NA	CHEMOTHERAPY	75	FALSE	239	NA	NA	NA	NA	12	NA	MG	MG	4800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	54600	NA
28	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D4952	3ce98d9a-0b40-4e25-9ba2-58794d288247	2010-10-15	AVASTIN	NA	TARGETED MOLECULAR THERAPY	90	FALSE	237	NA	NA	NA	NA	10	NA	MG	MG	440	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4400	NA
29	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D18368	3779457f-da47-48bc-bb01-e9f988c8a6fc	2011-11-14	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	761	FALSE	944	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	1750	NA
30	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D18366	13dd3946-99d8-43e0-b529-b79140588e52	2011-11-14	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	761	FALSE	944	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	5173	NA
31	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D18367	ba5c0262-3fbf-4e10-b18e-6d74b224da07	2011-11-14	OXALIPLATIN	NA	CHEMOTHERAPY	761	FALSE	944	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	2093	NA
32	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D18370	a2845a5c-66f7-4f7e-879d-33b8d06cb6ba	2011-11-14	FLUOROURACIL	NA	CHEMOTHERAPY	761	FALSE	946	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	59112	NA
33	57cdaa1c-4e94-4a28-ab3b-300c0457555f	TCGA.A6.2674	TCGA-A6-2674-D18369	a127ba7d-746f-46df-a7e8-d89a4a9945b6	2011-11-14	FLUOROURACIL	NA	CHEMOTHERAPY	761	FALSE	944	NA	NA	NA	NA	12	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	9852	NA
34	89a6384e-1cea-440b-9f17-d57cb0805174	TCGA.A6.2676	TCGA-A6-2676-D2538	6c3085ac-6d53-49fe-a8c0-4585b9ae2945	2010-10-25	OXALIPLATIN	NA	CHEMOTHERAPY	76	FALSE	111	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	360	NA
35	89a6384e-1cea-440b-9f17-d57cb0805174	TCGA.A6.2676	TCGA-A6-2676-D2540	5b1553bb-4c01-431e-b6c3-32fd8f32636b	2010-10-25	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	76	FALSE	111	NA	NA	NA	NA	3	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1750	NA
36	89a6384e-1cea-440b-9f17-d57cb0805174	TCGA.A6.2676	TCGA-A6-2676-D2539	716560b1-bfca-4513-9253-66e8ce01bffa	2010-10-25	5- FU	NA	CHEMOTHERAPY	76	FALSE	111	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1581	NA
37	89a6384e-1cea-440b-9f17-d57cb0805174	TCGA.A6.2676	TCGA-A6-2676-D2541	108e080e-0872-4a94-9b2a-b8990dc5b718	2010-10-25	5-FU	NA	CHEMOTHERAPY	76	FALSE	113	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9485	NA
38	d976782c-90c1-421d-b83c-7fc2617e2709	TCGA.A6.2677	TCGA-A6-2677-D2516	8bcbb764-ba22-4dca-98cb-b56141536845	2010-10-21	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	112	FALSE	617	NA	NA	NA	NA	9	ANCILLARY	MG	MG	600	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5400	NA
39	d976782c-90c1-421d-b83c-7fc2617e2709	TCGA.A6.2677	TCGA-A6-2677-D2514	fc790e21-4b95-4088-b256-6f1f47d9e46f	2010-10-21	5- FU	NA	CHEMOTHERAPY	112	FALSE	617	NA	NA	NA	NA	9	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5504	NA
40	d976782c-90c1-421d-b83c-7fc2617e2709	TCGA.A6.2677	TCGA-A6-2677-D2510	07c7b730-6602-4b6b-bb72-99d5b986f227	2010-10-21	OXALIPLATIN	NA	CHEMOTHERAPY	112	FALSE	252	NA	NA	NA	NA	9	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	976	NA
41	d976782c-90c1-421d-b83c-7fc2617e2709	TCGA.A6.2677	TCGA-A6-2677-D2518	f63c40b8-a6dc-4a65-b2ed-e7b458fd120a	2010-10-21	5-FU	NA	CHEMOTHERAPY	112	FALSE	252	NA	NA	NA	NA	9	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
42	3a785e32-7960-4c72-84c4-fb42c4dd86f1	TCGA.A6.2678	TCGA-A6-2678-D2530	b23a79b4-3671-4ae4-8a1b-461b91a9de9a	2010-10-25	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	60	FALSE	214	NA	NA	NA	NA	12	ANCILLARY	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9600	NA
43	3a785e32-7960-4c72-84c4-fb42c4dd86f1	TCGA.A6.2678	TCGA-A6-2678-D2528	62fa0dfa-21c9-4bbf-b910-f7f695e7f169	2010-10-25	5- FU	NA	CHEMOTHERAPY	60	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9588	NA
44	3a785e32-7960-4c72-84c4-fb42c4dd86f1	TCGA.A6.2678	TCGA-A6-2678-D2527	203e134c-6cea-4850-85fb-61d0590d6783	2010-10-25	OXALIPLATIN	NA	CHEMOTHERAPY	60	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1531	NA
45	3a785e32-7960-4c72-84c4-fb42c4dd86f1	TCGA.A6.2678	TCGA-A6-2678-D2529	a47a2727-c80a-47bf-82e3-43613c0f7535	2010-10-25	5- FU	NA	CHEMOTHERAPY	60	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	57528	NA
46	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6906	f0e8ad72-519f-4d7a-806d-4c861525fef7	2011-1-28	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	43	FALSE	106	NA	NA	NA	NA	5	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3350	NA
47	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6909	450d6b36-99fe-499b-93bc-548de8a785d9	2011-1-28	OXALIPLATIN	NA	CHEMOTHERAPY	231	FALSE	282	NA	NA	NA	NA	4	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	631	NA
48	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6905	06febf7e-3cba-45b5-a1fb-b6935217ea74	2011-1-28	OXALIPLATIN	NA	CHEMOTHERAPY	43	FALSE	106	NA	NA	NA	NA	5	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	783	NA
49	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6910	6daa7738-34ec-47e4-b489-6b1935932b6d	2011-1-28	5 FU	NA	CHEMOTHERAPY	231	FALSE	282	NA	NA	NA	NA	4	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	2972	NA
50	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6907	22f90f8f-9bd8-4e02-b69d-306207facef8	2011-1-28	5 FU	NA	CHEMOTHERAPY	43	FALSE	106	NA	NA	NA	NA	5	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3310	NA
51	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6911	273a2571-4f64-4350-b5d6-02ac929b2184	2011-1-28	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	231	FALSE	282	NA	NA	NA	NA	4	ANCILLARY	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	2950	NA
52	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6908	6d41c707-6c72-4ead-9e68-6677b9ae902d	2011-2-1	5 FU	NA	CHEMOTHERAPY	43	FALSE	108	NA	NA	NA	NA	5	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
53	77a44132-af22-4115-9fa2-78f2f74bf687	TCGA.A6.2682	TCGA-A6-2682-D6912	ce77ae94-e1dc-41e4-989a-8891fd070a58	2011-2-1	5 FU	NA	CHEMOTHERAPY	231	FALSE	284	NA	NA	NA	NA	4	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	17812	NA
54	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4968	62e33cf5-3a37-43dc-8fdb-c2258a9c910b	2010-10-18	5 FU	NA	CHEMOTHERAPY	322	FALSE	352	NA	NA	NA	NA	3	NA	MG	MG	3950	2	NA	NA	NA	PROGRESSION	NA	11850	NA
55	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4960	0b8a83b5-8223-41a9-b90f-e9b2b1a54ae8	2010-10-18	5 FU	NA	CHEMOTHERAPY	48	FALSE	287	NA	NA	NA	NA	16	NA	MG	MG	625	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10050	NA
56	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4962	1f797061-446e-4ba7-8117-30d480a8de8a	2010-10-18	5 FU	NA	CHEMOTHERAPY	48	FALSE	289	NA	NA	NA	NA	16	NA	MG	MG	4000	1	NA	NA	NA	ADJUVANT	NA	60525	NA
57	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4961	8e1fe263-78d0-40af-a3a7-8cb7a9185893	2010-10-18	LEVCOVORIN	NA	OTHER, SPECIFY IN NOTES	48	FALSE	287	NA	NA	NA	NA	16	ANCILLARY	MG	MG	625	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10050	NA
58	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4970	e3bedc74-6ed7-4959-8d5c-fb6ccfc417a5	2010-10-18	MITOMYCIN C	NA	CHEMOTHERAPY	443	FALSE	443	NA	NA	NA	NA	1	NA	MG	MG	16	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	16	NA
59	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4959	dfdef027-98d3-4ae2-82b7-d26157156291	2010-10-18	IRINOTECAN	NA	CHEMOTHERAPY	48	FALSE	287	NA	NA	NA	NA	12	NA	MG	MG	300	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3365	NA
60	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4966	616c70ed-f4d1-4ac8-bcd5-95fb57094d0a	2010-10-18	5 FU	NA	CHEMOTHERAPY	322	FALSE	350	NA	NA	NA	NA	3	NA	MG	MG	650	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	1950	NA
61	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4963	da116895-1b80-4709-94ed-70230241fc46	2010-10-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	105	FALSE	287	NA	NA	NA	NA	12	NA	MG	MG	275	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3210	NA
62	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4964	055caca7-c379-485e-8fa9-9f66029b7acb	2010-10-18	OXALIPLATIN	NA	CHEMOTHERAPY	322	FALSE	350	NA	NA	NA	NA	3	NA	MG	MG	140	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	420	NA
63	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4969	6a41add5-5273-4d56-b4b0-6b9065dd9ddf	2010-10-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	322	FALSE	350	NA	NA	NA	NA	3	NA	MG	MG	300	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	900	NA
64	fafd4576-0709-49e1-926f-ad1ee09907ec	TCGA.A6.2683	TCGA-A6-2683-D4967	b7e6fdf1-0994-4881-8f03-6dcd65d58c18	2010-10-18	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	322	FALSE	350	NA	NA	NA	NA	3	ANCILLARY AGENT	MG	MG	650	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	1950	NA
65	5116e3b4-2bac-40f5-8046-b9c1783faaa5	TCGA.A6.3807	TCGA-A6-3807-D2549	ed12b670-cdaf-487d-823f-f127a5dae4ed	2010-10-26	5-FU	NA	CHEMOTHERAPY	74	FALSE	242	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5515	NA
66	5116e3b4-2bac-40f5-8046-b9c1783faaa5	TCGA.A6.3807	TCGA-A6-3807-D2550	4a311e57-72d6-43e9-8b60-bd0c5e8c7bb6	2010-10-26	5 FU	NA	CHEMOTHERAPY	74	FALSE	244	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
67	5116e3b4-2bac-40f5-8046-b9c1783faaa5	TCGA.A6.3807	TCGA-A6-3807-D2547	5ef50513-5321-43a8-bc76-7532cf293e1c	2010-10-26	OXALIPLATIN	NA	CHEMOTHERAPY	74	FALSE	242	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1295	NA
68	5116e3b4-2bac-40f5-8046-b9c1783faaa5	TCGA.A6.3807	TCGA-A6-3807-D2548	96c56ecc-18dd-4d47-9052-82db0bb3e1b6	2010-10-26	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	74	FALSE	242	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5515	NA
69	b079a153-62f9-4026-a2f8-a1390168bbb9	TCGA.A6.4107	TCGA-A6-4107-D7151	4e2c6d3a-81e4-478e-9011-aa1486b9be7b	2011-2-4	OXALIPLATIN	NA	CHEMOTHERAPY	50	FALSE	197	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1414	NA
70	b079a153-62f9-4026-a2f8-a1390168bbb9	TCGA.A6.4107	TCGA-A6-4107-D7159	fc232b41-59b3-4ad0-a64c-ec240b773181	2011-2-4	5 FU	NA	CHEMOTHERAPY	50	FALSE	197	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7800	NA
71	b079a153-62f9-4026-a2f8-a1390168bbb9	TCGA.A6.4107	TCGA-A6-4107-D7158	f448b097-dfa4-4115-9bcc-0bfb694afc51	2011-2-4	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	50	FALSE	197	NA	NA	NA	NA	11	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4050	NA
72	b079a153-62f9-4026-a2f8-a1390168bbb9	TCGA.A6.4107	TCGA-A6-4107-D7160	efcd9394-67ff-45db-a8c8-2a14eafa65f6	2011-2-4	5 FU	NA	CHEMOTHERAPY	50	FALSE	199	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	46800	NA
73	dbbee8f5-d83d-4195-85cf-f89d327da0a9	TCGA.A6.5657	TCGA-A6-5657-D12385	06252ba3-ef9d-4962-b9fe-71a2a400610b	2011-5-31	5 FU	NA	CHEMOTHERAPY	40	FALSE	54	NA	NA	NA	NA	1	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3055	NA
74	dbbee8f5-d83d-4195-85cf-f89d327da0a9	TCGA.A6.5657	TCGA-A6-5657-D12386	5c18e079-5a69-4390-b00f-e806fc54ad99	2011-5-31	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	40	FALSE	54	NA	NA	NA	NA	1	LEUCOVORIN	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3050	NA
75	dbbee8f5-d83d-4195-85cf-f89d327da0a9	TCGA.A6.5657	TCGA-A6-5657-D12384	acfd75b3-5851-4076-9e2d-847babf77bf1	2011-5-31	OXALIPLATIN	NA	CHEMOTHERAPY	40	FALSE	54	NA	NA	NA	NA	1	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	357	NA
76	0dc41cd5-0672-407c-9b4a-0f5f3970aa54	TCGA.A6.5660	TCGA-A6-5660-D12415	609032be-e6d6-428c-909f-f0ba7b2bf342	2011-6-1	OXALIPLATIN	NA	CHEMOTHERAPY	82	FALSE	201	NA	NA	NA	NA	9	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1509	NA
77	0dc41cd5-0672-407c-9b4a-0f5f3970aa54	TCGA.A6.5660	TCGA-A6-5660-D12435	5f1e45b0-0859-4efb-a7e5-efb825e22fc3	2011-6-1	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	82	FALSE	243	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1350	NA
78	0dc41cd5-0672-407c-9b4a-0f5f3970aa54	TCGA.A6.5660	TCGA-A6-5660-D12432	75cb6eb3-4e9a-421e-a611-3bb290130d80	2011-6-1	5 FU	NA	CHEMOTHERAPY	82	FALSE	245	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	58512	NA
79	0dc41cd5-0672-407c-9b4a-0f5f3970aa54	TCGA.A6.5660	TCGA-A6-5660-D12418	ef6fde9e-c1b4-4576-aacb-a8869a522738	2011-6-1	5FU	NA	CHEMOTHERAPY	82	FALSE	243	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9752	NA
80	960d278c-c87d-42dc-ad28-42e010d8f0f1	TCGA.A6.5662	TCGA-A6-5662-D18218	33f69924-19e0-446d-8b33-b9e5d327e610	2011-11-8	FLUOROURACIL	NA	CHEMOTHERAPY	60	FALSE	397	NA	NA	NA	NA	23	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	NA	NA
81	960d278c-c87d-42dc-ad28-42e010d8f0f1	TCGA.A6.5662	TCGA-A6-5662-D18219	4ac04901-5785-41aa-9367-81ac00bfa8be	2011-11-8	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	60	FALSE	395	NA	NA	NA	NA	23	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	9488	NA
82	960d278c-c87d-42dc-ad28-42e010d8f0f1	TCGA.A6.5662	TCGA-A6-5662-D18220	00bf24a2-d995-4f9e-8c7f-8603f0c9c582	2011-11-8	XELODA	NA	CHEMOTHERAPY	426	FALSE	487	NA	NA	NA	NA	3	NA	MG	MG	NA	2	ORAL	NA	NA	OTHER	METASTATIC	NA	NA
83	960d278c-c87d-42dc-ad28-42e010d8f0f1	TCGA.A6.5662	TCGA-A6-5662-D18214	bb925bf4-00b9-42dd-93aa-ee0576cc19ef	2011-11-8	OXALIPLATIN	NA	CHEMOTHERAPY	60	FALSE	368	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	1977	NA
84	960d278c-c87d-42dc-ad28-42e010d8f0f1	TCGA.A6.5662	TCGA-A6-5662-D18217	ae0bab42-dcdf-4839-8310-26e7971cb270	2011-11-8	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	60	FALSE	395	NA	NA	NA	NA	23	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	1450	NA
85	960d278c-c87d-42dc-ad28-42e010d8f0f1	TCGA.A6.5662	TCGA-A6-5662-D18215	1caf1e4f-8aaa-43dc-9348-55b58fd5729e	2011-11-8	FLUOROURACIL	NA	CHEMOTHERAPY	60	FALSE	395	NA	NA	NA	NA	23	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	17194	NA
86	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15809	24d21731-0c40-44e8-8a1b-f6317f78b0d2	2011-9-1	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	301	TRUE	NA	NA	NA	NA	NA	1	NA	MG	MG	339	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	339	NA
87	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15811	dc3ca0c7-d4f6-4569-9e6a-3ab0421a3c62	2011-9-1	FLUOROURACIL	NA	CHEMOTHERAPY	301	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	736	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	2944	NA
88	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15777	fb3b27ca-4360-4a50-ba63-27801b3a2451	2011-8-31	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	231	FALSE	259	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	1016	NA
89	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15804	c3a8627d-8872-491d-a670-a382c96334f2	2011-9-1	IRINOTECAN	NA	CHEMOTHERAPY	301	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	1313	NA
90	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15812	7cad8852-e503-4c95-a4f7-ca6c11e54542	2011-9-1	FLUOROURACIL	NA	CHEMOTHERAPY	301	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	4416	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	17664	NA
91	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15775	2e02ab32-cfd5-4435-9bbb-d0d5cd74e318	2011-8-31	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	231	FALSE	273	NA	NA	NA	NA	4	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	300	NA
92	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15776	3b3a45ac-d472-4def-ba9b-d3b9b9b128ed	2011-8-31	FLUOROURACIL	NA	CHEMOTHERAPY	231	FALSE	275	NA	NA	NA	NA	4	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	17664	NA
93	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15774	cee020b0-05cb-4773-86d0-24f266a4c239	2011-8-31	OXALIPLATIN	NA	CHEMOTHERAPY	231	FALSE	273	NA	NA	NA	NA	4	NA	MG	MG	150	1	INTRAVENOUS	NA	NA	PALLIATIVE	NA	600	NA
94	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D15810	e2446b99-586f-4a4a-bdac-86b3baa79ee1	2011-9-1	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	301	TRUE	NA	NA	NA	NA	NA	4	ANCILLARY	MG	MG	NA	2	INTRAVENOUS	NA	NA	PALLIATIVE	NA	400	NA
95	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D33770	3BA99B8C-D023-41EB-BD42-E479F3EBDEDF	2012-7-16	IRINOTECAN	NA	CHEMOTHERAPY	301	FALSE	635	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
96	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D33771	07B9A3D8-5A9A-42A5-9C94-C102D4CFE178	2012-7-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	301	FALSE	391	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
97	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D33772	8249DBD2-17BC-46F8-BF68-4FF5E4D0BA0A	2012-7-16	LEUCOVORIN	NA	ANCILLARY	301	FALSE	635	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
98	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D33773	AE58752C-D8C7-469A-A65B-72ABF738364E	2012-7-16	FLUOROURACIL	NA	CHEMOTHERAPY	301	FALSE	635	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
99	f88c0259-58ff-4bcc-a777-7705cdbd8213	TCGA.A6.5664	TCGA-A6-5664-D33774	D8CFB903-4B53-4FDB-B226-2893791A7ADF	2012-7-16	FLUOROURACIL	NA	CHEMOTHERAPY	301	FALSE	637	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
100	28d03569-8717-40da-8989-70baf2b18f9f	TCGA.A6.5667	TCGA-A6-5667-D13423	db0386f8-b893-4fa3-bd66-33eac054e066	2011-6-27	OXALIPLATIN	NA	CHEMOTHERAPY	62	FALSE	160	NA	NA	NA	NA	8	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1026	NA
101	28d03569-8717-40da-8989-70baf2b18f9f	TCGA.A6.5667	TCGA-A6-5667-D13424	1f9e7cb8-aa9f-439d-b187-ba5f32ace987	2011-6-27	5 FU	NA	CHEMOTHERAPY	62	FALSE	223	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	8674	NA
102	28d03569-8717-40da-8989-70baf2b18f9f	TCGA.A6.5667	TCGA-A6-5667-D13426	b3dc8aab-d46f-4239-b2fa-2050e3721e71	2011-6-27	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	62	FALSE	223	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	925	NA
103	28d03569-8717-40da-8989-70baf2b18f9f	TCGA.A6.5667	TCGA-A6-5667-D13429	70fb07b7-8554-46f0-b865-ad8979c5ddba	2011-6-27	5FU	NA	CHEMOTHERAPY	62	FALSE	225	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	52044	NA
104	326c1637-ea91-4006-b440-d38420af1ae5	TCGA.A6.6137	TCGA-A6-6137-D18041	49b125ba-8d58-4fcc-8642-e6904a9d2eea	2011-11-3	FLUOROURACIL	NA	CHEMOTHERAPY	28	FALSE	218	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	18070	NA
105	326c1637-ea91-4006-b440-d38420af1ae5	TCGA.A6.6137	TCGA-A6-6137-D18039	2c4dc053-3db9-4821-8c56-1a278c580100	2011-11-3	OXALIPLATIN	NA	CHEMOTHERAPY	28	FALSE	211	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1619	NA
106	326c1637-ea91-4006-b440-d38420af1ae5	TCGA.A6.6137	TCGA-A6-6137-D18042	2b2b0da3-33bf-4d8f-bb44-a404410e818d	2011-11-3	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	28	FALSE	218	NA	NA	NA	NA	3	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1450	NA
107	21ddbfaa-1b21-4a2b-be2c-237dd69b20ff	TCGA.A6.6140	TCGA-A6-6140-D20354	ba8de936-a9ae-4858-ba46-6e682ed17c82	2012-1-9	OXALIPLATIN	NA	CHEMOTHERAPY	34	FALSE	181	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	985	NA
108	21ddbfaa-1b21-4a2b-be2c-237dd69b20ff	TCGA.A6.6140	TCGA-A6-6140-D20355	555b9c92-b76f-4e07-8f57-cde03e8e773d	2012-1-9	FLUOROURACIL	NA	CHEMOTHERAPY	34	FALSE	188	NA	NA	NA	NA	3	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	13801	NA
109	21ddbfaa-1b21-4a2b-be2c-237dd69b20ff	TCGA.A6.6140	TCGA-A6-6140-D20356	25c8886e-fa04-4b3a-ab0a-ed022afa6405	2012-1-9	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	34	FALSE	188	NA	NA	NA	NA	3	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1525	NA
110	58facedb-fcb8-4ecf-8338-2bfa4947acef	TCGA.A6.6141	TCGA-A6-6141-D21502	7fd0f190-15dc-4f21-bd5a-4b7a10378e8a	2012-2-14	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	60	FALSE	214	NA	NA	NA	NA	12	ANCILLARY	MG	MG	550	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4900	NA
111	58facedb-fcb8-4ecf-8338-2bfa4947acef	TCGA.A6.6141	TCGA-A6-6141-D21504	268e1286-26c0-4536-9f42-c7f5ea328d67	2012-2-14	5FU	NA	CHEMOTHERAPY	60	FALSE	216	NA	NA	NA	NA	12	NA	MG	MG	5150	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	61800	NA
112	58facedb-fcb8-4ecf-8338-2bfa4947acef	TCGA.A6.6141	TCGA-A6-6141-D21503	9b6fffa2-0197-4e5d-83b7-6799693aecb7	2012-2-14	5FU	NA	CHEMOTHERAPY	60	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10200	NA
113	58facedb-fcb8-4ecf-8338-2bfa4947acef	TCGA.A6.6141	TCGA-A6-6141-D21501	f3ddb88f-1ac9-4fe8-99c0-9c299af34ae0	2012-2-14	OXALIPLATIN	NA	CHEMOTHERAPY	60	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	2160	NA
114	c7c5348f-5708-45bf-b40e-1bf7c9348f60	TCGA.A6.6142	TCGA-A6-6142-D28730	16ab0b29-4834-4c89-aac1-63c46bbc2872	2012-2-26	FLUOROURACIL	NA	CHEMOTHERAPY	142	FALSE	340	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	44695	NA
115	c7c5348f-5708-45bf-b40e-1bf7c9348f60	TCGA.A6.6142	TCGA-A6-6142-D28727	698bfec7-fb37-43b9-aa00-8567f13f8a4a	2012-2-28	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	142	FALSE	338	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5048	NA
116	c7c5348f-5708-45bf-b40e-1bf7c9348f60	TCGA.A6.6142	TCGA-A6-6142-D28729	50512b15-54bb-4a84-b660-746ec73824f5	2012-2-28	FLUOROURACIL	NA	CHEMOTHERAPY	142	FALSE	338	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7545	NA
117	c7c5348f-5708-45bf-b40e-1bf7c9348f60	TCGA.A6.6142	TCGA-A6-6142-D28726	e3ae1ca9-0fc8-416c-b5b0-5b3bbebdb77b	2012-2-28	OXALIPLATIN	NA	CHEMOTHERAPY	142	FALSE	338	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1501	NA
118	65056295-8fcd-4f82-a3c9-a5acd79521fe	TCGA.A6.6648	TCGA-A6-6648-D17990	999f6885-13bd-4180-ac46-94bb3a6e01e1	2011-11-1	OXALIPLATIN	NA	NA	63	FALSE	91	NA	NA	NA	NA	1	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	540	NA
119	65056295-8fcd-4f82-a3c9-a5acd79521fe	TCGA.A6.6648	TCGA-A6-6648-D17989	a356522b-2132-46f8-a9d8-7c380201e8ba	2011-11-1	CETUXIMAB STUDY DRUG	NA	NA	63	FALSE	77	NA	NA	NA	NA	1	NA	MG	MG	1050	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	NA	NA
120	65056295-8fcd-4f82-a3c9-a5acd79521fe	TCGA.A6.6648	TCGA-A6-6648-D17991	4786b23e-8b48-48c6-bfee-d431500e366a	2011-11-1	LEUCOVORIN	NA	NA	63	FALSE	91	NA	NA	NA	NA	1	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	2540	NA
121	65056295-8fcd-4f82-a3c9-a5acd79521fe	TCGA.A6.6648	TCGA-A6-6648-D17992	186076eb-7755-4b35-8e49-fd1156a8beea	2011-11-1	5 FU	NA	NA	63	FALSE	93	NA	NA	NA	NA	1	NA	MG	MG	6300	1	INTRAVENOUS	NA	NA	OTHER	METASTATIC	18900	NA
122	39b6ae01-c97b-4234-8a28-208fdf170432	TCGA.A6.6649	TCGA-A6-6649-D19131	b90ac8b4-29d6-490c-bacc-1b28fc09e6ca	2011-12-2	OXALIPLATIN	NA	CHEMOTHERAPY	68	FALSE	68	NA	NA	NA	NA	1	NA	MG	MG	197	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	197	NA
123	39b6ae01-c97b-4234-8a28-208fdf170432	TCGA.A6.6649	TCGA-A6-6649-D19132	e68051a4-b42e-43a5-9114-81f73b2852ff	2011-12-2	FLUOROURACIL	NA	CHEMOTHERAPY	68	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4713	NA
124	39b6ae01-c97b-4234-8a28-208fdf170432	TCGA.A6.6649	TCGA-A6-6649-D19176	5a80c12d-0cbd-4019-9d7c-d07152df3d3d	2011-12-5	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	68	FALSE	145	NA	NA	NA	NA	6	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	575	NA
125	39b6ae01-c97b-4234-8a28-208fdf170432	TCGA.A6.6649	TCGA-A6-6649-D19161	6d48ab98-3956-42ff-b409-3acaa4fe5334	2011-12-5	FLUOROURACIL	NA	CHEMOTHERAPY	68	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	28277	NA
126	0ec6ed47-db99-4273-9823-ffbde6a77091	TCGA.A6.6651	TCGA-A6-6651-D18530	1d1b2876-8f89-4115-a26e-e437e8174fc0	2011-11-18	FLUOROURACIL	NA	CHEMOTHERAPY	77	FALSE	247	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9228	NA
127	0ec6ed47-db99-4273-9823-ffbde6a77091	TCGA.A6.6651	TCGA-A6-6651-D18528	a528abe3-9cc5-4833-8f81-9086291a9c00	2011-11-18	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	77	FALSE	247	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1150	NA
128	0ec6ed47-db99-4273-9823-ffbde6a77091	TCGA.A6.6651	TCGA-A6-6651-D18527	8ab6ac64-e947-4bbd-85c6-2e8d7b472d87	2011-11-18	OXALIPLATIN	NA	CHEMOTHERAPY	77	FALSE	205	NA	NA	NA	NA	9	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1304	NA
129	0ec6ed47-db99-4273-9823-ffbde6a77091	TCGA.A6.6651	TCGA-A6-6651-D18529	74c23414-80cb-4ae3-bcf2-a52122118f4f	2011-11-18	FLUOROURACIL	NA	CHEMOTHERAPY	77	FALSE	249	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	55368	NA
130	96ac1f4b-79b0-4517-8caf-fc05abcaaf4f	TCGA.A6.6652	TCGA-A6-6652-D30459	8eac1749-f057-4382-af62-127ed368dd65	2012-4-18	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	86	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
131	96ac1f4b-79b0-4517-8caf-fc05abcaaf4f	TCGA.A6.6652	TCGA-A6-6652-D30908	c13ce170-4baf-4507-9eda-d0f4897f8151	2012-4-18	LEUCOVORIN	NA	ANCILLARY	86	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
132	96ac1f4b-79b0-4517-8caf-fc05abcaaf4f	TCGA.A6.6652	TCGA-A6-6652-D30907	3a8d9c47-535d-49bc-8901-149af8ad9273	2012-4-19	OXALIPLATIN	NA	CHEMOTHERAPY	86	FALSE	254	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
133	96ac1f4b-79b0-4517-8caf-fc05abcaaf4f	TCGA.A6.6652	TCGA-A6-6652-D30909	f0c12b8f-7c6f-4be3-8c5e-c2e71bf85879	2012-4-19	FLUOROURACIL	NA	CHEMOTHERAPY	86	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
134	96ac1f4b-79b0-4517-8caf-fc05abcaaf4f	TCGA.A6.6652	TCGA-A6-6652-D30910	2cfdae08-2b02-48d5-b9ea-12f073efa831	2012-4-19	FLUOROURACIL	NA	CHEMOTHERAPY	86	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
135	81e7cca8-2d71-4446-9692-872c2fe68d0a	TCGA.A6.6654	TCGA-A6-6654-D29549	85858a5a-2a25-49e2-964e-5508bef1349c	2012-3-22	OXALIPLATIN	NA	CHEMOTHERAPY	136	FALSE	276	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1640	NA
136	81e7cca8-2d71-4446-9692-872c2fe68d0a	TCGA.A6.6654	TCGA-A6-6654-D29785	4904bd04-a129-4cfa-9261-34f59d0ab226	2012-3-28	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	136	FALSE	290	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	6100	NA
137	81e7cca8-2d71-4446-9692-872c2fe68d0a	TCGA.A6.6654	TCGA-A6-6654-D29787	f603532b-fd11-437c-ac3b-3467cf35c2ef	2012-3-28	5 FU	NA	CHEMOTHERAPY	136	FALSE	292	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	60300	NA
138	81e7cca8-2d71-4446-9692-872c2fe68d0a	TCGA.A6.6654	TCGA-A6-6654-D29786	a044ff74-4c3b-4a2e-b545-074c96ff4752	2012-3-28	5 FU	NA	CHEMOTHERAPY	136	FALSE	290	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10050	NA
139	b54865b6-824e-4163-b759-21a6eacc98ce	TCGA.A6.6781	TCGA-A6-6781-D29222	d19e09cd-4f33-4fdc-98be-45cb96a40be2	2012-3-12	FLUOROURACIL	NA	CHEMOTHERAPY	32	FALSE	221	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10832	NA
140	b54865b6-824e-4163-b759-21a6eacc98ce	TCGA.A6.6781	TCGA-A6-6781-D29217	8bf9874b-b3a3-4f9f-a2fd-d5f1c20afc24	2012-3-12	OXALIPLATIN	NA	CHEMOTHERAPY	32	FALSE	158	NA	NA	NA	NA	8	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1308	NA
141	b54865b6-824e-4163-b759-21a6eacc98ce	TCGA.A6.6781	TCGA-A6-6781-D29223	15555c80-b097-4e8e-a035-7b621c250a15	2012-3-12	FLUOROURACIL	NA	CHEMOTHERAPY	32	FALSE	223	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	64992	NA
142	b54865b6-824e-4163-b759-21a6eacc98ce	TCGA.A6.6781	TCGA-A6-6781-D29219	c2c8bb68-9f4d-4197-8e3e-b42eb78201c6	2012-3-12	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	32	FALSE	221	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	2000	NA
143	DD7A53EE-CB08-40C4-9935-51D1CA17E9E8	TCGA.A6.A565	TCGA-A6-A565-D42141	9F6660B3-7566-45BC-8FAC-96CC0EFC39B4	2013-4-12	5FU	NA	CHEMOTHERAPY	NA	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
144	DD7A53EE-CB08-40C4-9935-51D1CA17E9E8	TCGA.A6.A565	TCGA-A6-A565-D42143	297A845E-BC66-4A57-9FFD-7244BD48D447	2013-4-12	LEUCOVORIN	NA	ANCILLARY	NA	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
145	DD7A53EE-CB08-40C4-9935-51D1CA17E9E8	TCGA.A6.A565	TCGA-A6-A565-D42144	5BD8C24D-85AD-4D45-8D64-5DF0775A2B08	2013-4-12	OXALIPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
146	790266BC-C252-43F4-85D1-1B06EE529CF8	TCGA.A6.A566	TCGA-A6-A566-D42252	74C0E183-B802-4EFC-BD08-FCBB9930035D	2013-4-15	OXALIPLATIN	NA	CHEMOTHERAPY	76	FALSE	237	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
147	790266BC-C252-43F4-85D1-1B06EE529CF8	TCGA.A6.A566	TCGA-A6-A566-D42254	F111779F-8AA9-4640-9CCE-7CA1D108F7CE	2013-4-15	FLUOROURACIL	NA	CHEMOTHERAPY	76	FALSE	251	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
148	790266BC-C252-43F4-85D1-1B06EE529CF8	TCGA.A6.A566	TCGA-A6-A566-D42262	843A4503-B4D5-4C02-8919-45C327BA724F	2013-4-15	LEUCOVORIN	NA	ANCILLARY	76	FALSE	251	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
149	790266BC-C252-43F4-85D1-1B06EE529CF8	TCGA.A6.A566	TCGA-A6-A566-D42264	4F12D452-984F-40FF-A277-8CDEDCAA4B42	2013-4-15	FLUOROURACIL	NA	CHEMOTHERAPY	76	FALSE	253	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
150	74A0264D-1D31-430D-9A88-E7334C8AA96C	TCGA.A6.A56B	TCGA-A6-A56B-D42088	07E34E9E-9C88-42C3-9978-261BEA4751F6	2013-4-10	FLUOROURACIL	NA	CHEMOTHERAPY	82	FALSE	110	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
151	74A0264D-1D31-430D-9A88-E7334C8AA96C	TCGA.A6.A56B	TCGA-A6-A56B-D42089	4222D044-05CB-4518-9BAC-DB508925FB7E	2013-4-10	LEUCOVORIN	NA	ANCILLARY	82	FALSE	236	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
152	74A0264D-1D31-430D-9A88-E7334C8AA96C	TCGA.A6.A56B	TCGA-A6-A56B-D42090	0D9ACB99-4600-4500-A13E-6F8C9A486B11	2013-4-10	OXALIPLATIN	NA	CHEMOTHERAPY	82	FALSE	236	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
153	74A0264D-1D31-430D-9A88-E7334C8AA96C	TCGA.A6.A56B	TCGA-A6-A56B-D42091	06E9668D-3E5E-4CC8-A928-31E4FFE59F82	2013-4-10	FLUOROURACIL	NA	CHEMOTHERAPY	82	FALSE	238	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
154	74A0264D-1D31-430D-9A88-E7334C8AA96C	TCGA.A6.A56B	TCGA-A6-A56B-D42092	E4C65970-C55E-48AF-A90D-85AC6045F18C	2013-4-10	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	82	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
155	4881A390-C4E4-48B4-AE66-140C64A87614	TCGA.A6.A5ZU	TCGA-A6-A5ZU-D51210	0A3C8862-F409-415A-AA9C-4FAF2B00D046	2013-11-13	OXALIPLATIN	NA	CHEMOTHERAPY	105	FALSE	245	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
156	4881A390-C4E4-48B4-AE66-140C64A87614	TCGA.A6.A5ZU	TCGA-A6-A5ZU-D51211	B0A001F1-04BE-42CE-827C-E68CCC501CA3	2013-11-13	LEUCOVORIN	NA	ANCILLARY	105	FALSE	272	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
157	4881A390-C4E4-48B4-AE66-140C64A87614	TCGA.A6.A5ZU	TCGA-A6-A5ZU-D51212	16A5338C-26CA-4F43-A103-F39855600088	2013-11-13	FLUOROURACIL	NA	CHEMOTHERAPY	105	FALSE	272	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
158	4881A390-C4E4-48B4-AE66-140C64A87614	TCGA.A6.A5ZU	TCGA-A6-A5ZU-D51213	8049EF92-87B1-4195-A843-E594E482D74A	2013-11-13	FLUOROURACIL	NA	CHEMOTHERAPY	105	FALSE	274	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
159	67ba29e7-f294-4dcd-9630-ad768c22c588	TCGA.AA.3494	TCGA-AA-3494-D37440	96AC2755-D00C-43F2-AF85-250EEE267909	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	92	FALSE	184	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
160	67ba29e7-f294-4dcd-9630-ad768c22c588	TCGA.AA.3494	TCGA-AA-3494-D37441	22607192-21C1-46B1-9007-82F8207BD46F	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	92	FALSE	184	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
161	67ba29e7-f294-4dcd-9630-ad768c22c588	TCGA.AA.3494	TCGA-AA-3494-D37442	8D724D6C-49CF-4BD7-840D-2DF9295914B5	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	184	FALSE	792	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
162	67ba29e7-f294-4dcd-9630-ad768c22c588	TCGA.AA.3494	TCGA-AA-3494-D37443	43259854-0480-42D0-98A2-F62606319067	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	212	FALSE	334	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
163	67ba29e7-f294-4dcd-9630-ad768c22c588	TCGA.AA.3494	TCGA-AA-3494-D37444	2F9DDCC4-8761-4EF4-9C8C-9487B219A252	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	334	FALSE	1065	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
164	67ba29e7-f294-4dcd-9630-ad768c22c588	TCGA.AA.3494	TCGA-AA-3494-D37445	D326355B-264D-4391-9026-C1B14D59A663	2012-12-3	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	792	FALSE	1065	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
165	c4d74653-d26b-4e51-aee0-82ee3d42f883	TCGA.AA.3517	TCGA-AA-3517-D37446	4B85C082-B80A-4078-9ACE-04A97F890D2C	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	821	FALSE	1065	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
166	c4d74653-d26b-4e51-aee0-82ee3d42f883	TCGA.AA.3517	TCGA-AA-3517-D37447	F87AD537-F5FE-44DB-8AF5-E6409F211742	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	821	FALSE	1155	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
167	c4d74653-d26b-4e51-aee0-82ee3d42f883	TCGA.AA.3517	TCGA-AA-3517-D37448	F1363524-2B4B-4BEF-AA3A-4C1332C21770	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	821	FALSE	1127	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
168	c4d74653-d26b-4e51-aee0-82ee3d42f883	TCGA.AA.3517	TCGA-AA-3517-D37449	21ACA8B4-7BE6-4C0B-910C-F3B95A355C06	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	1004	FALSE	1065	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
169	c4d74653-d26b-4e51-aee0-82ee3d42f883	TCGA.AA.3517	TCGA-AA-3517-D37450	0DADF926-9A5E-4BB7-A9EF-9122111FAC39	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	821	FALSE	1127	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
170	9dcb4e16-b582-4cd0-87cf-04f480ec2cec	TCGA.AA.3542	TCGA-AA-3542-D37453	977CAA41-165B-4CFC-966E-54A9B8400418	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	30	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
171	9dcb4e16-b582-4cd0-87cf-04f480ec2cec	TCGA.AA.3542	TCGA-AA-3542-D37454	C5B20829-CD88-4658-A64D-378175527DD5	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	30	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
172	9dcb4e16-b582-4cd0-87cf-04f480ec2cec	TCGA.AA.3542	TCGA-AA-3542-D37455	FA7BF379-E96D-4367-95B2-B00912AE20E1	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	30	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
173	2dced66c-1f0d-4039-a5e5-54cca77c16e9	TCGA.AA.3548	TCGA-AA-3548-D37456	93B49DE9-A03F-4B39-B6E3-8BD4788D0490	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	304	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
174	2dced66c-1f0d-4039-a5e5-54cca77c16e9	TCGA.AA.3548	TCGA-AA-3548-D37457	F7F32AFA-44B0-4A6A-9750-E45777A0FCE0	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	304	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
175	2dced66c-1f0d-4039-a5e5-54cca77c16e9	TCGA.AA.3548	TCGA-AA-3548-D37458	E07A2591-6A1E-4F73-A3D3-516AC60E8D80	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	31	FALSE	304	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
176	2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2	TCGA.AA.3560	TCGA-AA-3560-D37463	03F2E068-151A-44F5-A6DD-2D04EC99B0BF	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
177	2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2	TCGA.AA.3560	TCGA-AA-3560-D37464	BADECE76-E2D5-4E8F-AA08-EFAF10FA5EAB	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
178	2d02bd7a-5beb-4e43-9ccb-18d89c9d5ca2	TCGA.AA.3560	TCGA-AA-3560-D37465	1791EB2A-6782-4676-B313-4B8F73B36DD0	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
179	127f738d-afa1-42f6-a9a0-f33806667b84	TCGA.AA.3562	TCGA-AA-3562-D37469	2E29FE7B-26FB-403C-A4E4-94AF2131E766	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	62	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
180	127f738d-afa1-42f6-a9a0-f33806667b84	TCGA.AA.3562	TCGA-AA-3562-D37470	72A86237-359D-4847-82EA-73CC155CEE90	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	62	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
181	127f738d-afa1-42f6-a9a0-f33806667b84	TCGA.AA.3562	TCGA-AA-3562-D37471	F7B983DE-0C58-48A5-A415-655D45D9C330	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	62	FALSE	182	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
182	d9fb85c3-ade1-47bf-8159-170f81eb130f	TCGA.AA.3662	TCGA-AA-3662-D37403	7ABB665F-CA40-4858-A7EB-4D5B975E83F4	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	62	FALSE	184	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
183	c616f95f-4ea1-4019-8c17-041878085c88	TCGA.AA.3678	TCGA-AA-3678-D37451	A670C33A-E236-4318-9A49-820A1091CD06	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	30	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
184	c616f95f-4ea1-4019-8c17-041878085c88	TCGA.AA.3678	TCGA-AA-3678-D37452	12C68CEF-0CF7-4B84-9CF2-95B80C236707	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	30	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
185	d17a2ab0-faef-40de-a87d-1291868b200d	TCGA.AA.3679	TCGA-AA-3679-D37459	190D149A-867E-4A51-AC82-5253C7C98D08	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	61	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
186	d17a2ab0-faef-40de-a87d-1291868b200d	TCGA.AA.3679	TCGA-AA-3679-D37460	547AD4AC-2155-44BE-A664-9C74D157121B	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
187	d17a2ab0-faef-40de-a87d-1291868b200d	TCGA.AA.3679	TCGA-AA-3679-D37461	840B021A-FBFE-4ED4-944D-A1B47F95B6A6	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	61	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
188	d17a2ab0-faef-40de-a87d-1291868b200d	TCGA.AA.3679	TCGA-AA-3679-D37462	AED3958D-DA22-4743-AE53-4EF7F530F02B	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	61	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
189	f3b9defb-88ed-4c95-9feb-7197d869676c	TCGA.AA.3680	TCGA-AA-3680-D37466	CC56A6EE-BBEF-44F2-876A-0AB791B6F9B1	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	90	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
190	f3b9defb-88ed-4c95-9feb-7197d869676c	TCGA.AA.3680	TCGA-AA-3680-D37467	60CA88E0-83DA-4B36-BE1D-F18C24A1D8E7	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	90	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
191	f3b9defb-88ed-4c95-9feb-7197d869676c	TCGA.AA.3680	TCGA-AA-3680-D37468	AE2B4E60-C99E-48F0-8B68-5A121C279908	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	90	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
192	bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d	TCGA.AA.3692	TCGA-AA-3692-D37486	C5BC9915-EBBF-4648-A0FA-9F09297020A2	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	669	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
193	bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d	TCGA.AA.3692	TCGA-AA-3692-D37487	781EDB20-2832-4C12-A42B-CA09749FD454	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	669	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
194	bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d	TCGA.AA.3692	TCGA-AA-3692-D37488	CFE1096A-3879-429A-8A98-B8F0C2BBD23B	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	31	FALSE	883	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
195	bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d	TCGA.AA.3692	TCGA-AA-3692-D37489	FDE51FAB-DA6B-4B36-A1E9-31903F8BBFDA	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	31	FALSE	669	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
196	bce3ce45-4fb3-4d8e-9ec7-d24427c2ba4d	TCGA.AA.3692	TCGA-AA-3692-D37490	086DF84A-9DAF-4E7C-8F35-043714901C01	2012-12-3	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	883	FALSE	883	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
197	57a2044d-20cc-4d02-b268-ce570a0fabe3	TCGA.AA.3713	TCGA-AA-3713-D37500	9597EA4B-6886-4161-8F9B-825AF0C1FD21	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	244	FALSE	456	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
198	7dfbc0ed-e684-4966-8b59-fb6b9e80c129	TCGA.AA.3841	TCGA-AA-3841-D37472	906C70DA-8292-4D49-8219-0605D0D83B41	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	59	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
199	7dfbc0ed-e684-4966-8b59-fb6b9e80c129	TCGA.AA.3841	TCGA-AA-3841-D37473	61C33BB9-928A-45B2-9AAE-FE545603CFCF	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	59	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
200	7dfbc0ed-e684-4966-8b59-fb6b9e80c129	TCGA.AA.3841	TCGA-AA-3841-D37474	4C4944D0-9643-4CFB-9322-92554CEE4DA5	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	59	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
201	80311cf5-7e18-4545-92ad-c4b7dd5c9677	TCGA.AA.3842	TCGA-AA-3842-D37475	ADAADEA5-5CC5-4AA4-BA47-150B275E7461	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	59	FALSE	212	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
202	80311cf5-7e18-4545-92ad-c4b7dd5c9677	TCGA.AA.3842	TCGA-AA-3842-D37476	8940A6B1-1A17-428B-9929-BD7948D255D9	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	59	FALSE	212	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
203	80311cf5-7e18-4545-92ad-c4b7dd5c9677	TCGA.AA.3842	TCGA-AA-3842-D37477	2CE1D74C-9405-46AD-BC26-F102D37AE18D	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	59	FALSE	212	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
204	4f786107-3cf5-4ab3-bba4-f399dee23f0e	TCGA.AA.3844	TCGA-AA-3844-D37478	44AB9D89-3E3C-461B-ADFD-22214943A595	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	59	FALSE	59	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
205	4f786107-3cf5-4ab3-bba4-f399dee23f0e	TCGA.AA.3844	TCGA-AA-3844-D37479	E2943FD1-7025-4ADC-A4C1-E1DA1ABA85AF	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	393	FALSE	424	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
206	4f786107-3cf5-4ab3-bba4-f399dee23f0e	TCGA.AA.3844	TCGA-AA-3844-D37480	69922414-9463-4B03-9D7F-D4E028CF5C63	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	393	FALSE	424	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
207	4f786107-3cf5-4ab3-bba4-f399dee23f0e	TCGA.AA.3844	TCGA-AA-3844-D37481	0984FEF0-6099-46AD-9223-E34AFE4BC94C	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	393	FALSE	424	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
208	4f786107-3cf5-4ab3-bba4-f399dee23f0e	TCGA.AA.3844	TCGA-AA-3844-D37482	BAC19AFA-78D6-45CA-B1DB-BC08D71E505E	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	393	FALSE	393	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
209	ac6a3df9-41b1-4e5a-a15e-f44481384c23	TCGA.AA.3860	TCGA-AA-3860-D37483	A46935F0-B18B-4309-974A-98F5C9843423	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	184	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
210	ac6a3df9-41b1-4e5a-a15e-f44481384c23	TCGA.AA.3860	TCGA-AA-3860-D37484	66C6E947-FA93-4F75-B11C-3B9D3AB625D9	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	184	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
211	ac6a3df9-41b1-4e5a-a15e-f44481384c23	TCGA.AA.3860	TCGA-AA-3860-D37485	572E00AF-360A-426A-8377-D9A247751050	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	184	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
212	39d3b5b3-d51e-4d77-a8aa-2977fa734fab	TCGA.AA.3869	TCGA-AA-3869-D37491	DA64549C-BBD5-4E27-B064-182E142FC782	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	92	FALSE	365	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
213	39d3b5b3-d51e-4d77-a8aa-2977fa734fab	TCGA.AA.3869	TCGA-AA-3869-D37492	ECAD1937-2E65-4E73-959F-DF8DA17FBAD6	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	365	FALSE	396	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
214	39d3b5b3-d51e-4d77-a8aa-2977fa734fab	TCGA.AA.3869	TCGA-AA-3869-D37493	7BB5F82C-B67C-4405-840E-B5EB1385A49D	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	365	FALSE	761	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
215	39d3b5b3-d51e-4d77-a8aa-2977fa734fab	TCGA.AA.3869	TCGA-AA-3869-D37494	70A670E1-B68A-4FDE-804F-E54569FE7655	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	365	FALSE	761	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
216	39d3b5b3-d51e-4d77-a8aa-2977fa734fab	TCGA.AA.3869	TCGA-AA-3869-D37495	689C50C2-8AC3-4B58-BA25-84BE69AE99F1	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	365	FALSE	580	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
217	39d3b5b3-d51e-4d77-a8aa-2977fa734fab	TCGA.AA.3869	TCGA-AA-3869-D37496	634D660B-99EA-421D-A10D-A9B924C6AB3B	2012-12-3	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	608	FALSE	761	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
218	beb63625-d9bf-4ccd-bc53-635b53d24240	TCGA.AA.3870	TCGA-AA-3870-D37497	A524BF8C-3693-4873-8114-6CC5177E2C3D	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	30	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
219	beb63625-d9bf-4ccd-bc53-635b53d24240	TCGA.AA.3870	TCGA-AA-3870-D37498	D94292F6-51D0-454D-B608-9D1D674D5981	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	30	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
220	beb63625-d9bf-4ccd-bc53-635b53d24240	TCGA.AA.3870	TCGA-AA-3870-D37499	C0DDC956-119F-4DAE-B704-8917CA66D803	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	30	FALSE	153	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
221	81f6b141-2195-4091-9cd3-dfb022663949	TCGA.AA.3930	TCGA-AA-3930-D37377	7BFAB3A6-37A3-4A3A-9D2D-FF9B6CAE4884	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	NA	FALSE	31	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
222	5c24435e-8e50-42c2-80c7-919b1cad0133	TCGA.AA.3955	TCGA-AA-3955-D37378	923A811E-F19F-43E7-84A9-1C1FBA0ABD65	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	28	FALSE	181	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
223	5c24435e-8e50-42c2-80c7-919b1cad0133	TCGA.AA.3955	TCGA-AA-3955-D37379	CDACF96B-2A58-4F42-8195-990F0E68F7C0	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	28	FALSE	150	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
224	86a9e44f-728e-48e4-9e1b-682b023f7c0a	TCGA.AA.3967	TCGA-AA-3967-D37420	88E98323-5636-42CA-B3E4-61BD63936922	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	60	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
225	86a9e44f-728e-48e4-9e1b-682b023f7c0a	TCGA.AA.3967	TCGA-AA-3967-D37421	ED66B9C8-A20C-4B19-914C-BA8AFC2CB529	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	60	FALSE	213	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
226	86a9e44f-728e-48e4-9e1b-682b023f7c0a	TCGA.AA.3967	TCGA-AA-3967-D37422	845B10DA-CB7B-4517-ADFB-318C6F3A217E	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	90	FALSE	182	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
227	10994156-7c2f-420e-aeb8-11d566b3d5e4	TCGA.AA.3971	TCGA-AA-3971-D37423	5F0380B5-59E5-4BB8-B7AC-1DD2C7E02145	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
228	10994156-7c2f-420e-aeb8-11d566b3d5e4	TCGA.AA.3971	TCGA-AA-3971-D37424	F71B9357-6613-4BF8-8F2D-9B49B35F1912	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
229	10994156-7c2f-420e-aeb8-11d566b3d5e4	TCGA.AA.3971	TCGA-AA-3971-D37425	969A32A8-5D14-4A37-9062-DAF425EA1C5B	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
230	93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1	TCGA.AA.3972	TCGA-AA-3972-D37426	45D2A60B-C35E-4BAC-9769-B1D5C0153FED	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	60	FALSE	1246	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
231	93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1	TCGA.AA.3972	TCGA-AA-3972-D37427	2DAFDB28-A410-42B2-AF63-E120355C65F7	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	60	FALSE	1246	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
232	93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1	TCGA.AA.3972	TCGA-AA-3972-D37428	DB748C7A-3F23-4440-959F-0652EF839B25	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	1277	FALSE	1369	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
233	93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1	TCGA.AA.3972	TCGA-AA-3972-D37429	96844749-3509-4378-99E8-349FDEC7EFE8	2012-12-3	5-FLUORUORACIL	NA	CHEMOTHERAPY	1277	FALSE	1369	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
234	93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1	TCGA.AA.3972	TCGA-AA-3972-D37430	A6074E5B-5C69-431C-837C-BFE344753B77	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	1277	FALSE	1369	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
235	93cd5d07-e0d3-40f8-ae7f-beadb1efb7c1	TCGA.AA.3972	TCGA-AA-3972-D37431	D468F9E0-47B4-4132-AD13-0ABB40C4E310	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1246	FALSE	1369	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
236	e8841edf-e070-425b-b4d4-bbb2115f9dbd	TCGA.AA.3973	TCGA-AA-3973-D37432	02288D76-A58F-4E92-B19E-08FA0A8A09A3	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	305	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
237	e8841edf-e070-425b-b4d4-bbb2115f9dbd	TCGA.AA.3973	TCGA-AA-3973-D37433	8C12A90B-FDED-4D29-B7FA-DCDA7A730754	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	305	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
238	e8841edf-e070-425b-b4d4-bbb2115f9dbd	TCGA.AA.3973	TCGA-AA-3973-D37434	33052D56-5F11-49F8-BABA-6F23D89EB61D	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	31	FALSE	305	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
239	e8841edf-e070-425b-b4d4-bbb2115f9dbd	TCGA.AA.3973	TCGA-AA-3973-D37435	830E21DE-6412-4062-B970-4C321B01D3D4	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	NA	FALSE	305	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
240	14efca0c-882d-4fba-b15c-64af6e213b80	TCGA.AA.3976	TCGA-AA-3976-D37436	71E44A11-E322-4B4A-9E01-EAA0DA75FD43	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	30	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
241	14efca0c-882d-4fba-b15c-64af6e213b80	TCGA.AA.3976	TCGA-AA-3976-D37437	899F6FBF-C49A-43F7-9946-8B8993D26711	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	30	FALSE	242	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
242	14efca0c-882d-4fba-b15c-64af6e213b80	TCGA.AA.3976	TCGA-AA-3976-D37438	22945031-905D-47E4-814D-EB4815FCF8B5	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	30	FALSE	61	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
243	750770db-53cf-4021-a8c2-5e0ddb97fef5	TCGA.AA.3994	TCGA-AA-3994-D37439	09F57FC8-2E45-4B15-83F1-490E1762A214	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	30	FALSE	334	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
244	60ad2c8a-6bbf-43fc-ae73-cc1f6d6c163c	TCGA.AA.A00F	TCGA-AA-A00F-D37417	A79924C7-E384-46D8-9AA7-C45D0D21E753	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	213	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
245	60ad2c8a-6bbf-43fc-ae73-cc1f6d6c163c	TCGA.AA.A00F	TCGA-AA-A00F-D37418	41FF725E-E12B-4A08-8828-37F0E889E44E	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	213	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
246	60ad2c8a-6bbf-43fc-ae73-cc1f6d6c163c	TCGA.AA.A00F	TCGA-AA-A00F-D37419	157B2E65-0CA0-485B-9762-7F17FCBD7934	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	213	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
247	56e612e8-2c29-4782-be79-2813cc8dd2e6	TCGA.AA.A00J	TCGA-AA-A00J-D37416	B3019D2B-1967-4313-8010-AE45C7D73ADA	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	245	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
248	62d39be5-f029-4eb8-8b00-46470e06a755	TCGA.AA.A00Q	TCGA-AA-A00Q-D37413	14525E0B-771C-4858-85EA-04411066C462	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	334	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
249	62d39be5-f029-4eb8-8b00-46470e06a755	TCGA.AA.A00Q	TCGA-AA-A00Q-D37414	551F6AA8-2C03-4ACC-9760-585B262DAC5F	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	334	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
250	62d39be5-f029-4eb8-8b00-46470e06a755	TCGA.AA.A00Q	TCGA-AA-A00Q-D37415	2FFB89A0-6358-4261-AD46-64CC67C11629	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	334	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
251	091e3084-04ee-4497-893c-d46226dec78f	TCGA.AA.A00U	TCGA-AA-A00U-D37380	573E799A-7A71-49F9-A262-26BF0DCB98ED	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
252	091e3084-04ee-4497-893c-d46226dec78f	TCGA.AA.A00U	TCGA-AA-A00U-D37381	DD9FE9D1-175B-495F-9E2D-9DF63C15AD70	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
253	091e3084-04ee-4497-893c-d46226dec78f	TCGA.AA.A00U	TCGA-AA-A00U-D37382	EA070337-0D97-467F-B588-9F256BE4C9F4	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
254	0712566e-3371-4715-95f1-5b792e72d758	TCGA.AA.A010	TCGA-AA-A010-D37410	F4C201FC-604D-4378-BF80-1D0B46DC40EF	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	0	FALSE	183	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
255	0712566e-3371-4715-95f1-5b792e72d758	TCGA.AA.A010	TCGA-AA-A010-D37411	196D63A5-A0C3-4567-B52C-C80754DC5D60	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	0	FALSE	183	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
256	0712566e-3371-4715-95f1-5b792e72d758	TCGA.AA.A010	TCGA-AA-A010-D37412	5E8AE646-9F65-4EE8-BED1-F1874A391471	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	0	FALSE	183	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
257	e2edbf3f-25d8-49aa-b656-2a59c3b99aeb	TCGA.AA.A01D	TCGA-AA-A01D-D37404	4F739C3B-57E6-4AB5-8F2A-79326FE773E6	2012-12-3	CAPECITABINE	NA	CHEMOTHERAPY	61	FALSE	273	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
258	e2edbf3f-25d8-49aa-b656-2a59c3b99aeb	TCGA.AA.A01D	TCGA-AA-A01D-D37405	C597CB1C-8B1F-4EAE-AACF-2ACB2C0B0267	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	153	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
259	e2edbf3f-25d8-49aa-b656-2a59c3b99aeb	TCGA.AA.A01D	TCGA-AA-A01D-D37406	9E59767B-446A-4F48-BFEF-20BDB4731B47	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	214	FALSE	273	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
260	e2edbf3f-25d8-49aa-b656-2a59c3b99aeb	TCGA.AA.A01D	TCGA-AA-A01D-D37407	F2A4FAE7-D172-454F-8F86-44237D0514DF	2012-12-3	MITOMYCIN	NA	CHEMOTHERAPY	273	TRUE	304	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
261	e2edbf3f-25d8-49aa-b656-2a59c3b99aeb	TCGA.AA.A01D	TCGA-AA-A01D-D37408	2F4FDF3B-F5D5-4507-975B-07A38AC4D75C	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	214	FALSE	273	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
262	e2edbf3f-25d8-49aa-b656-2a59c3b99aeb	TCGA.AA.A01D	TCGA-AA-A01D-D37409	45839A4B-3333-43FE-ABE2-E6FCFE5D837D	2012-12-3	PANITUMUMAB	NA	TARGETED MOLECULAR THERAPY	273	FALSE	304	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
263	132229e5-947d-43e9-a54c-a97d4be7d604	TCGA.AA.A01F	TCGA-AA-A01F-D37400	A2B884E1-ED59-4356-819B-62212890077A	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	62	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
264	132229e5-947d-43e9-a54c-a97d4be7d604	TCGA.AA.A01F	TCGA-AA-A01F-D37401	988E2E95-014A-4780-BDFE-813A1F8ACD26	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	62	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
265	132229e5-947d-43e9-a54c-a97d4be7d604	TCGA.AA.A01F	TCGA-AA-A01F-D37402	AED5627D-9A57-44F6-82C4-CDAC2CB1EE4C	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	62	FALSE	215	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
266	a72dd578-3a6f-4807-a843-4a942500944e	TCGA.AA.A01K	TCGA-AA-A01K-D37397	3A2C3BC3-3631-4F1C-BB13-DAC6A294936E	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
267	a72dd578-3a6f-4807-a843-4a942500944e	TCGA.AA.A01K	TCGA-AA-A01K-D37398	6796D8BC-15FF-4367-ADF9-C70A1F2D542B	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
268	a72dd578-3a6f-4807-a843-4a942500944e	TCGA.AA.A01K	TCGA-AA-A01K-D37399	4BEE62E4-B052-4D7B-B1AE-7020CE37EC3F	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	243	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
269	97f6c8d3-09a0-4128-8f10-41e736648a5f	TCGA.AA.A01R	TCGA-AA-A01R-D37394	D951161C-677D-4A62-9684-DD8794840413	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	60	FALSE	820	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
270	97f6c8d3-09a0-4128-8f10-41e736648a5f	TCGA.AA.A01R	TCGA-AA-A01R-D37395	EF93527A-31EB-43F2-98FB-343C3AE08F54	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	669	FALSE	820	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
271	97f6c8d3-09a0-4128-8f10-41e736648a5f	TCGA.AA.A01R	TCGA-AA-A01R-D37396	8EF3060A-3D3D-4F10-83A7-29CB9FDF2D8A	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	669	FALSE	820	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
272	f87c6dcc-1a9e-4df5-962c-1f946e2611f8	TCGA.AA.A01T	TCGA-AA-A01T-D37392	45AADB1F-5899-4657-BE24-711FD3CEFC2C	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	184	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
273	f87c6dcc-1a9e-4df5-962c-1f946e2611f8	TCGA.AA.A01T	TCGA-AA-A01T-D37393	70E04694-EC9B-4596-B5C3-25BC492B1919	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	61	FALSE	184	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
274	dd4be58e-da22-4bcd-bf4c-2b9e60ffda19	TCGA.AA.A02F	TCGA-AA-A02F-D37387	F6A5DA6A-5BF9-4460-ACFE-CBA48519AAB4	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	59	FALSE	1127	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
275	dd4be58e-da22-4bcd-bf4c-2b9e60ffda19	TCGA.AA.A02F	TCGA-AA-A02F-D37388	71DCC297-9D24-453F-A455-1F3541C60CE2	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	59	FALSE	1127	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
276	dd4be58e-da22-4bcd-bf4c-2b9e60ffda19	TCGA.AA.A02F	TCGA-AA-A02F-D37389	FD42DB4E-C958-48D6-BE29-86FBF6F1B815	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	59	FALSE	1127	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
277	dd4be58e-da22-4bcd-bf4c-2b9e60ffda19	TCGA.AA.A02F	TCGA-AA-A02F-D37390	FFAE6F6B-0040-4DAB-8FD5-F053839270BC	2012-12-3	OXALIPLATIN	NA	CHEMOTHERAPY	670	FALSE	700	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
278	dd4be58e-da22-4bcd-bf4c-2b9e60ffda19	TCGA.AA.A02F	TCGA-AA-A02F-D37391	9C785800-15D7-46C2-95F4-282E60286F9C	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	59	FALSE	1096	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
279	10881458-55b2-41d1-8358-4ee6ccb8ec85	TCGA.AA.A02K	TCGA-AA-A02K-D37383	284D9612-89A5-4F4D-82AD-D73C214BF630	2012-12-3	FOLINIC ACID	NA	CHEMOTHERAPY	31	FALSE	275	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
280	10881458-55b2-41d1-8358-4ee6ccb8ec85	TCGA.AA.A02K	TCGA-AA-A02K-D37384	DA114F4F-D777-4640-A175-AC51FF4D0346	2012-12-3	5-FLUOROURACIL	NA	CHEMOTHERAPY	31	FALSE	275	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
281	10881458-55b2-41d1-8358-4ee6ccb8ec85	TCGA.AA.A02K	TCGA-AA-A02K-D37385	B72BBC44-9B88-4103-84CC-157C43ADFAE9	2012-12-3	IRINOTECAN	NA	CHEMOTHERAPY	31	FALSE	275	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
282	10881458-55b2-41d1-8358-4ee6ccb8ec85	TCGA.AA.A02K	TCGA-AA-A02K-D37386	AD48478E-2CDC-4B13-B6E6-61CAE4FEE9E9	2012-12-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	31	FALSE	275	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
283	955464c8-9c62-430c-87b8-107db5c980a8	TCGA.AD.6889	TCGA-AD-6889-D47707	2285FF7F-F87C-4232-BE93-94606723E640	2013-8-28	XELODA	NA	CHEMOTHERAPY	42	FALSE	NA	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
284	b76d1de7-6447-474d-bf67-77e0bb2da73a	TCGA.AD.6901	TCGA-AD-6901-D47119	CCB03758-E07C-42D8-B066-C6C9C73796AC	2013-8-22	XELODA	NA	CHEMOTHERAPY	61	FALSE	214	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
285	5e7074a6-5011-4dc5-950c-41365dbc6d09	TCGA.AD.6964	TCGA-AD-6964-D47096	80AE8305-E49C-40BD-A961-158C125E4D50	2013-8-22	FOLFOX	NA	CHEMOTHERAPY	63	FALSE	214	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
286	c8de215d-53a4-4e6c-be58-5887a8094815	TCGA.AD.6965	TCGA-AD-6965-D47146	6FD88F0C-8E92-4A08-99F2-27BA67D1E2A1	2013-8-22	OXALIPLATIN	NA	CHEMOTHERAPY	42	FALSE	196	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
287	c8de215d-53a4-4e6c-be58-5887a8094815	TCGA.AD.6965	TCGA-AD-6965-D47150	F1C233D6-4F49-413E-86F4-3272232F0EB1	2013-8-22	AVASTIN	NA	CHEMOTHERAPY	665	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
288	c8de215d-53a4-4e6c-be58-5887a8094815	TCGA.AD.6965	TCGA-AD-6965-D47186	6F3BBC44-C6FD-4257-8A06-C3B96F2C35BE	2013-8-22	IRINOTECAN	NA	CHEMOTHERAPY	665	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
289	c8de215d-53a4-4e6c-be58-5887a8094815	TCGA.AD.6965	TCGA-AD-6965-D47187	8C42CF4F-ED5B-413A-83DC-A315C8C6ED8A	2013-8-22	5-FU	NA	CHEMOTHERAPY	665	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
290	c8de215d-53a4-4e6c-be58-5887a8094815	TCGA.AD.6965	TCGA-AD-6965-D72561	3ED672C0-CD23-4467-B904-44021DC2B3A9	2015-7-16	5FU	NA	CHEMOTHERAPY	42	FALSE	196	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
291	c8de215d-53a4-4e6c-be58-5887a8094815	TCGA.AD.6965	TCGA-AD-6965-D72562	9904C076-BC2D-4783-B9E1-4E983C9C15D4	2015-7-16	LEUCOVORIN	NA	ANCILLARY	42	FALSE	196	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
292	6baf61b6-ae5b-42f0-adc9-0d26fda231f7	TCGA.AY.4070	TCGA-AY-4070-D3537	68a125c7-6377-4105-866f-eef2a90ed085	2010-11-18	5FU	NA	CHEMOTHERAPY	64	FALSE	146	NA	NA	NA	NA	7	NA	MG/M2	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
293	6baf61b6-ae5b-42f0-adc9-0d26fda231f7	TCGA.AY.4070	TCGA-AY-4070-D3554	86b293fc-06bc-4c36-956a-a2b8525fd5da	2010-11-18	XELODA	NA	CHEMOTHERAPY	212	FALSE	239	NA	NA	NA	NA	3	NA	MG/M2	NA	NA	2	ORAL	NA	NA	PROGRESSION	NA	NA	NA
294	6baf61b6-ae5b-42f0-adc9-0d26fda231f7	TCGA.AY.4070	TCGA-AY-4070-D20674	5be9b21f-28da-47a0-8c21-25f848f38f4f	2012-1-19	OXALIPLATIN	NA	CHEMOTHERAPY	64	FALSE	146	NA	NA	NA	NA	7	NA	MG/M2	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
295	6baf61b6-ae5b-42f0-adc9-0d26fda231f7	TCGA.AY.4070	TCGA-AY-4070-D20685	2a9501ce-b4e0-48b7-bcc1-39ccd2b189df	2012-1-19	IRINOTECAN	NA	CHEMOTHERAPY	212	FALSE	239	NA	NA	NA	NA	3	NA	MG/M2	NA	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
296	14cc6f5b-5692-471e-98b4-ae200b3d8fed	TCGA.AY.5543	TCGA-AY-5543-D19916	465c3779-5d7e-4817-8fd0-d76b54c4dfff	2012-1-4	5FU	NA	CHEMOTHERAPY	60	FALSE	251	NA	NA	NA	NA	12	NA	MG/M2	NA	2800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
297	14cc6f5b-5692-471e-98b4-ae200b3d8fed	TCGA.AY.5543	TCGA-AY-5543-D19914	aea534a6-3b75-4e1b-b24f-56f269f3fa86	2012-1-4	OXALIPLATIN	NA	CHEMOTHERAPY	60	FALSE	251	NA	NA	NA	NA	12	NA	MG/M2	NA	85	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
298	14cc6f5b-5692-471e-98b4-ae200b3d8fed	TCGA.AY.5543	TCGA-AY-5543-D19915	3fe50558-8e39-4aa2-9862-d96cf58a0c6f	2012-1-4	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	60	FALSE	251	NA	NA	NA	NA	12	ANCILLARY AGENT	MG/M2	NA	200	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
299	35c9264f-34ec-4d75-ab80-aaac86108fc8	TCGA.AY.6386	TCGA-AY-6386-D21747	9cf53d79-7012-4ee9-bd20-adcaaa841a4c	2012-2-20	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	73	FALSE	246	NA	NA	NA	NA	12	ANCILLARY AGENT	MG/M2	NA	200	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
300	35c9264f-34ec-4d75-ab80-aaac86108fc8	TCGA.AY.6386	TCGA-AY-6386-D21748	beee8dab-75b8-4e6b-a1a8-bd422660278c	2012-2-20	OXALIPLATIN	NA	CHEMOTHERAPY	73	FALSE	246	NA	NA	NA	NA	12	NA	MG/M2	NA	85	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
301	35c9264f-34ec-4d75-ab80-aaac86108fc8	TCGA.AY.6386	TCGA-AY-6386-D21745	dcd152ef-7b0f-4554-8701-587498c2fb1b	2012-2-20	5FU	NA	CHEMOTHERAPY	73	FALSE	246	NA	NA	NA	NA	12	NA	MG/M2	NA	2800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
302	C6F6C032-5D4E-4028-AED0-24A587620354	TCGA.AY.A8YK	TCGA-AY-A8YK-D66229	809D0B32-3328-4D10-8884-A1A6FAAA9656	2014-10-6	5FU	NA	CHEMOTHERAPY	69	FALSE	286	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
303	C6F6C032-5D4E-4028-AED0-24A587620354	TCGA.AY.A8YK	TCGA-AY-A8YK-D66236	B61E9618-2291-43AD-97BE-8C4C0B8DF4FD	2014-10-6	OXALIPLATIN	NA	CHEMOTHERAPY	69	FALSE	146	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
304	C6F6C032-5D4E-4028-AED0-24A587620354	TCGA.AY.A8YK	TCGA-AY-A8YK-D66237	8E470806-DD81-425B-AAD4-C6CFF304F12C	2014-10-6	BEVACIZUMAB	NA	IMMUNOTHERAPY	83	FALSE	111	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
305	3d8fd9b2-9aa2-4c81-8843-535ae66d6140	TCGA.AZ.4308	TCGA-AZ-4308-D20205	309da8a6-9b7a-4a25-b3cf-72f765484963	2012-1-6	FOLINIC ACID	NA	CHEMOTHERAPY	53	FALSE	196	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
306	3d8fd9b2-9aa2-4c81-8843-535ae66d6140	TCGA.AZ.4308	TCGA-AZ-4308-D31198	fb00dbc1-fe8e-499f-a828-6f339a1095ba	2012-4-25	AVASTIN	NA	CHEMOTHERAPY	50	FALSE	191	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
307	3d8fd9b2-9aa2-4c81-8843-535ae66d6140	TCGA.AZ.4308	TCGA-AZ-4308-D72532	2D0F4E33-22EC-4990-80E0-158C353540BB	2015-7-11	LEUCOVORIN	NA	CHEMOTHERAPY	53	FALSE	196	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
308	c59d90a6-9cda-426d-b8ea-41f0a87033d5	TCGA.AZ.4323	TCGA-AZ-4323-D30624	d2b47817-125a-48ac-85c5-bda942ea8cb8	2012-4-13	OXALIPLATIN	NA	CHEMOTHERAPY	27	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
309	bf69a4ce-ec7e-4752-a86d-dcc80e3c9a57	TCGA.AZ.4615	TCGA-AZ-4615-D20214	9550a75a-dc24-400b-92c2-7665b57c6325	2012-1-6	XELODA	NA	CHEMOTHERAPY	89	FALSE	264	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
310	e703af88-c05f-4d7b-b225-d640e4d1a2a5	TCGA.AZ.4616	TCGA-AZ-4616-D31069	ee6f05bf-df9b-4ced-8826-a19eafb73cc6	2012-4-23	XELODA	NA	CHEMOTHERAPY	113	FALSE	NA	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
311	e588714a-7753-4c3c-abb6-eaf1aab53ab3	TCGA.AZ.4682	TCGA-AZ-4682-D30816	4f6af62d-0d2a-4536-9c92-c4fc73ff58d5	2012-4-17	AVASTIN	NA	CHEMOTHERAPY	103	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
312	e588714a-7753-4c3c-abb6-eaf1aab53ab3	TCGA.AZ.4682	TCGA-AZ-4682-D31200	4198e4c8-9a65-40d9-9a74-0e231eb35917	2012-4-25	CAMPTOSAR	NA	CHEMOTHERAPY	100	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
313	e588714a-7753-4c3c-abb6-eaf1aab53ab3	TCGA.AZ.4682	TCGA-AZ-4682-D31202	c8a170f2-d094-44f4-a6a1-e2b2b06f7ae6	2012-4-25	FOLINIC ACID	NA	CHEMOTHERAPY	100	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
314	e588714a-7753-4c3c-abb6-eaf1aab53ab3	TCGA.AZ.4682	TCGA-AZ-4682-D31203	5e969a71-8847-4099-91f4-03911df0d7ab	2012-4-25	5-FU	NA	CHEMOTHERAPY	100	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
315	cac80259-3a26-4a99-b0d3-13454068e6ed	TCGA.AZ.4684	TCGA-AZ-4684-D30846	2bb28cde-e6d2-4b5b-be40-2e267a44ce8b	2012-4-25	FOLFOX	NA	CHEMOTHERAPY	22	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
316	aee20b98-df51-4ead-86cc-0d5f60a74b90	TCGA.AZ.6600	TCGA-AZ-6600-D34149	B95F4311-53FF-4CA7-975C-9F2B508C6EA8	2012-7-31	CPT-11	NA	CHEMOTHERAPY	122	FALSE	144	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
317	aee20b98-df51-4ead-86cc-0d5f60a74b90	TCGA.AZ.6600	TCGA-AZ-6600-D34150	BC76525A-EFC5-4518-8284-ED321B464F5E	2012-7-31	5-FU	NA	CHEMOTHERAPY	122	FALSE	144	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
318	aee20b98-df51-4ead-86cc-0d5f60a74b90	TCGA.AZ.6600	TCGA-AZ-6600-D34151	D03EF7A0-DCCB-4070-9D2D-89B401069535	2012-7-31	LEUCOVORIN	NA	CHEMOTHERAPY	122	FALSE	144	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
319	849031de-ac8a-4012-9362-d192512997f1	TCGA.AZ.6605	TCGA-AZ-6605-D34155	06300BAA-C980-4F05-B262-22DD1912B178	2012-7-31	FOLFOX	NA	CHEMOTHERAPY	56	FALSE	105	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
320	c8d6fe73-3504-42a5-9723-e1916fba8208	TCGA.AZ.6606	TCGA-AZ-6606-D34173	911D9E4B-F7D6-4148-8474-7711805F5561	2012-8-1	FOLFIRI	NA	CHEMOTHERAPY	59	FALSE	103	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
321	c8d6fe73-3504-42a5-9723-e1916fba8208	TCGA.AZ.6606	TCGA-AZ-6606-D34174	410BCD90-40D4-47F1-82A9-917465D28CD4	2012-8-1	5 FU	NA	CHEMOTHERAPY	165	FALSE	165	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
322	26a41625-4680-47b2-afa9-6a72b148e1c0	TCGA.CA.5254	TCGA-CA-5254-D70898	6190AB74-8B52-4AE1-AE80-30570CA4BD5A	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	50	FALSE	204	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
323	26a41625-4680-47b2-afa9-6a72b148e1c0	TCGA.CA.5254	TCGA-CA-5254-D70899	B70702AA-8E86-45A0-BF1D-43057580E3D6	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	50	FALSE	204	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
324	26a41625-4680-47b2-afa9-6a72b148e1c0	TCGA.CA.5254	TCGA-CA-5254-D70900	7C8A2022-E668-46AD-A54F-04CFC91BA4D1	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	50	FALSE	204	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
325	563d67a1-f1ba-4722-aa2d-9b35b1689468	TCGA.CA.5255	TCGA-CA-5255-D70893	5BCC76C0-2AA1-4924-ABBC-BFEED0763489	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	164	FALSE	331	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
326	563d67a1-f1ba-4722-aa2d-9b35b1689468	TCGA.CA.5255	TCGA-CA-5255-D70894	E910330C-3E93-4D6E-9D24-CF762F6FEA96	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	164	FALSE	331	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
327	563d67a1-f1ba-4722-aa2d-9b35b1689468	TCGA.CA.5255	TCGA-CA-5255-D70896	F33C7ED2-B534-4BF8-9791-20E4CFC321B2	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	164	FALSE	331	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
328	17633a60-e12b-4a7c-bd8a-c16341ddc606	TCGA.CA.5256	TCGA-CA-5256-D70889	528CCCB5-6DF2-456B-BDF6-1CE1FB302BA5	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	20	FALSE	206	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
329	17633a60-e12b-4a7c-bd8a-c16341ddc606	TCGA.CA.5256	TCGA-CA-5256-D70890	25467727-76C8-4DBE-BB26-2F51C287E804	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	20	FALSE	206	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
330	17633a60-e12b-4a7c-bd8a-c16341ddc606	TCGA.CA.5256	TCGA-CA-5256-D70891	A8E9F2B5-BB30-43C6-81DA-577AEFBC529C	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	20	FALSE	206	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
331	65ab030d-39f2-48ab-80ac-90cb1faa823a	TCGA.CA.5796	TCGA-CA-5796-D70884	92A15186-B406-49DF-A981-9E54C965CEB6	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	30	FALSE	183	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
332	65ab030d-39f2-48ab-80ac-90cb1faa823a	TCGA.CA.5796	TCGA-CA-5796-D70885	1B08A697-B28B-4C55-A3F5-C60EDC93DF2E	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	30	FALSE	183	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
333	65ab030d-39f2-48ab-80ac-90cb1faa823a	TCGA.CA.5796	TCGA-CA-5796-D70887	5D7CAFE8-C18A-445B-9AB4-094EB5D34245	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	30	FALSE	183	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
334	794131b8-f4be-4f15-b3b9-6f0b10a5a38b	TCGA.CA.6715	TCGA-CA-6715-D70876	2A89E239-0062-4F9E-8946-8BD697383709	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	44	FALSE	227	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
335	794131b8-f4be-4f15-b3b9-6f0b10a5a38b	TCGA.CA.6715	TCGA-CA-6715-D70878	A3B59973-3FCE-44E7-99DE-11330368700D	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	44	FALSE	227	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
336	794131b8-f4be-4f15-b3b9-6f0b10a5a38b	TCGA.CA.6715	TCGA-CA-6715-D70879	56419CB6-A31A-4499-A503-8EBEDBCC1950	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	44	FALSE	227	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
337	95a54459-3fac-42d5-8ec1-ed66d971d64d	TCGA.CA.6716	TCGA-CA-6716-D70865	5685C16B-388E-4342-84D9-0156CCCC3F43	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	42	FALSE	226	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
338	95a54459-3fac-42d5-8ec1-ed66d971d64d	TCGA.CA.6716	TCGA-CA-6716-D70867	5260D8B7-8E40-4BB5-BA69-A1C26F5C97F2	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	42	FALSE	226	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
339	95a54459-3fac-42d5-8ec1-ed66d971d64d	TCGA.CA.6716	TCGA-CA-6716-D70869	1824EB06-30F9-4726-A683-F2313A935926	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	42	FALSE	226	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
340	268c01b3-d2ce-44c0-a2fe-ea846a1253cc	TCGA.CA.6717	TCGA-CA-6717-D70860	0CBC9366-A33A-4693-8D94-0F35F6A6D07B	2015-3-10	OXALIPLATIN	NA	CHEMOTHERAPY	128	FALSE	318	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
341	268c01b3-d2ce-44c0-a2fe-ea846a1253cc	TCGA.CA.6717	TCGA-CA-6717-D70861	885F39FF-3425-4DF0-9AA1-21700116EE9A	2015-3-10	5-FLUOROURACIL	NA	CHEMOTHERAPY	128	FALSE	318	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
342	268c01b3-d2ce-44c0-a2fe-ea846a1253cc	TCGA.CA.6717	TCGA-CA-6717-D70862	9D0EF700-AC63-4DFE-A616-CF5C42039D73	2015-3-10	FOLINIC ACID	NA	CHEMOTHERAPY	128	FALSE	318	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
343	73f9681a-f9ef-4880-bd16-93624fd117c6	TCGA.CK.4947	TCGA-CK-4947-D9803	3ebddb06-e6bd-46ca-ac04-5ad4941844f6	2011-3-31	FOLINIC ACID	NA	OTHER, SPECIFY IN NOTES	448	FALSE	448	NA	NA	NA	NA	1	NA	MG/KG	MG/M2	200	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
344	73f9681a-f9ef-4880-bd16-93624fd117c6	TCGA.CK.4947	TCGA-CK-4947-D14537	51ec77f6-eaf7-41d2-8888-10797b91ff48	2011-8-2	FLUOROURACIL	NA	CHEMOTHERAPY	448	FALSE	448	NA	NA	NA	NA	1	NA	MG/M2	NA	600	NA	INTRAVENOUS	NA	NA	PALLIATIVE	NA	NA	NA
345	73f9681a-f9ef-4880-bd16-93624fd117c6	TCGA.CK.4947	TCGA-CK-4947-D14535	74525cbb-3c61-46d2-a8ee-503e66ff4ad3	2011-8-2	OXALIPLATIN	NA	CHEMOTHERAPY	448	FALSE	448	NA	NA	NA	NA	1	NA	MG/M2	NA	85	NA	INTRAVENOUS	NA	NA	PALLIATIVE	NA	NA	NA
346	c293a148-a88c-4fb3-b2f4-e64e918044f9	TCGA.CK.4950	TCGA-CK-4950-D9825	c3ab7778-ee30-49f8-8136-659414100e0f	2011-4-1	FOLFOX	NA	CHEMOTHERAPY	49	FALSE	259	NA	NA	NA	NA	11	NA	MG	NA	2280	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
347	c293a148-a88c-4fb3-b2f4-e64e918044f9	TCGA.CK.4950	TCGA-CK-4950-D72393	1AC65ADB-8FFA-41F4-B7F5-36245EE1E553	2015-6-9	OXALIPLATIN	NA	CHEMOTHERAPY	49	FALSE	237	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
348	c293a148-a88c-4fb3-b2f4-e64e918044f9	TCGA.CK.4950	TCGA-CK-4950-D72394	A516255A-FACF-432D-BCC2-21F20A2A4338	2015-6-9	LEUCOVORIN	NA	ANCILLARY	49	FALSE	237	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
349	c293a148-a88c-4fb3-b2f4-e64e918044f9	TCGA.CK.4950	TCGA-CK-4950-D72395	41B9C695-3F5C-4EC0-B94D-60E1AE573021	2015-6-9	FLUOROURACIL	NA	CHEMOTHERAPY	49	FALSE	237	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
350	c8d7eb0f-2502-4277-a8ef-435b08f3c863	TCGA.CM.4743	TCGA-CM-4743-D8949	84924e2f-cab0-49c8-988d-1c3f4b53769a	2011-1-17	CAPECITABINE	NA	CHEMOTHERAPY	108	FALSE	235	NA	NA	NA	NA	6	NA	MG	MG	1500	1	ORAL	NA	NA	ADJUVANT	NA	9000	NA
351	56eb96a4-d2c2-42fb-b26c-1a80012bcb8e	TCGA.CM.4747	TCGA-CM-4747-D8958	a5741352-2a80-414c-8129-cf4997f46eb0	2011-1-17	FLUOROURACIL	NA	CHEMOTHERAPY	98	FALSE	252	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5360	NA
352	56eb96a4-d2c2-42fb-b26c-1a80012bcb8e	TCGA.CM.4747	TCGA-CM-4747-D8956	cbe7aceb-2049-4af1-b953-31d04eb6176f	2011-1-17	FLUOROURACIL	NA	CHEMOTHERAPY	98	FALSE	252	NA	NA	NA	NA	12	NA	MG	MG	2500	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	30000	NA
353	56eb96a4-d2c2-42fb-b26c-1a80012bcb8e	TCGA.CM.4747	TCGA-CM-4747-D8959	559f4cb9-8305-40ca-8643-2a5077baa4b1	2011-1-17	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	98	FALSE	252	NA	NA	NA	NA	12	ANCILLARY	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5360	NA
354	56eb96a4-d2c2-42fb-b26c-1a80012bcb8e	TCGA.CM.4747	TCGA-CM-4747-D8964	41e99931-ad70-4652-8a54-e3f9d30b28b4	2011-1-17	OXALIPLATIN	NA	CHEMOTHERAPY	98	FALSE	225	NA	NA	NA	NA	10	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
355	56eb96a4-d2c2-42fb-b26c-1a80012bcb8e	TCGA.CM.4747	TCGA-CM-4747-D8966	75a88a6f-c67a-4802-a0fe-6962eb8331f4	2011-1-17	PEGFILGRASTIM	NA	OTHER, SPECIFY IN NOTES	114	FALSE	254	NA	NA	NA	NA	11	ANCILLARY	MG	MG	6	1	SUBCUTANEOUS	NA	NA	ADJUVANT	NA	66	NA
356	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D8954	5087eeea-c516-4cce-a7cb-06359bc561a4	2011-1-17	OXALIPLATIN	NA	CHEMOTHERAPY	75	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	185	NA
357	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D8952	3ff80bdd-5baf-45b1-a8ff-9fddc1b4a34f	2011-1-17	FLUOROURACIL	NA	CHEMOTHERAPY	75	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10200	NA
358	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D8953	1c8484ba-c8e5-4fdb-a458-c6da76730125	2011-1-17	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	75	FALSE	229	NA	NA	NA	NA	12	ANCILLARY	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10200	NA
359	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D8951	b1b3b1e6-0123-4bf9-96d0-4ce2774d4221	2011-1-17	FLUOROURACIL	NA	CHEMOTHERAPY	75	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	30010.5	NA
360	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33829	6589D529-DF32-4845-817C-4B19554CF287	2012-7-19	OXALIPLATIN	NA	CHEMOTHERAPY	153	FALSE	214	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
361	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33830	276FBB94-B1E7-4154-961B-0B78CE2BCFBE	2012-7-19	IRINOTECAN HCL	NA	CHEMOTHERAPY	276	FALSE	365	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
362	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33832	711D3DA5-341B-4192-9BEE-893C7345A568	2012-7-19	BEVACIZUMAB	NA	CHEMOTHERAPY	304	FALSE	335	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
363	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33833	575D70B6-ED2E-42D8-8622-7DE4314F43B0	2012-7-19	FLOXURIDINE	NA	CHEMOTHERAPY	396	FALSE	518	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
364	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33835	76DE2CCB-26BA-4C2B-AD02-F3CEE6D3643A	2012-7-19	LEUCOVORIN CALCIUM	NA	ANCILLARY	396	FALSE	518	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
365	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33837	A0608323-E407-4B3A-8409-32F07626D6C4	2012-7-19	CETUXIMAB	NA	CHEMOTHERAPY	670	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
366	cd845618-4cc4-49c2-9055-c171d4c24ee1	TCGA.CM.4748	TCGA-CM-4748-D33838	BD739F62-0557-4954-8F18-02B97C1411C4	2012-7-19	IRINOTECAN HCL	NA	CHEMOTHERAPY	670	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
367	c777a777-373a-4773-9566-6c373261f00a	TCGA.CM.4750	TCGA-CM-4750-D9915	0d015d60-0914-4165-8746-4ed9f2f0a395	2011-1-17	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	49	FALSE	210	NA	NA	NA	NA	12	ANCILLARY	MG	MG/DAY	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5690	NA
368	c777a777-373a-4773-9566-6c373261f00a	TCGA.CM.4750	TCGA-CM-4750-D9916	0d47bdc8-bec1-4090-b4be-f7bfe1c3ea6a	2011-1-17	FLUOROURACIL	NA	CHEMOTHERAPY	49	FALSE	210	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVESICAL	NA	NA	ADJUVANT	NA	6950	NA
369	c777a777-373a-4773-9566-6c373261f00a	TCGA.CM.4750	TCGA-CM-4750-D9917	f1f12f68-b591-4801-b1a8-66c57856433c	2011-1-17	FLUOROURACIL	NA	CHEMOTHERAPY	49	FALSE	210	NA	NA	NA	NA	11	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	41450	NA
370	c777a777-373a-4773-9566-6c373261f00a	TCGA.CM.4750	TCGA-CM-4750-D9914	52a49370-98c2-41f8-a0bf-4f67af1d0fae	2011-1-17	OXALIPLATIN	NA	CHEMOTHERAPY	49	FALSE	168	NA	NA	NA	NA	9	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1075	NA
371	e3ca9046-9634-4332-b19f-88b18110f941	TCGA.CM.4751	TCGA-CM-4751-D16811	7814e988-0038-4dcb-8e97-89c1cbbb1f6f	2011-9-26	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	54	FALSE	208	NA	NA	NA	NA	12	ANCILLARY	MG	MG	900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9450	NA
372	e3ca9046-9634-4332-b19f-88b18110f941	TCGA.CM.4751	TCGA-CM-4751-D16809	ea440ecc-252e-439d-80d0-8b9ddf66e13c	2011-9-26	FLUOROURACIL	NA	CHEMOTHERAPY	54	FALSE	208	NA	NA	NA	NA	12	NA	MG	MG	2800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	28200	NA
373	e3ca9046-9634-4332-b19f-88b18110f941	TCGA.CM.4751	TCGA-CM-4751-D16808	ebbc8014-2a28-4c55-a8cf-ad5368fff25c	2011-9-26	FLUOROURACIL	NA	CHEMOTHERAPY	54	FALSE	208	NA	NA	NA	NA	12	NA	MG	MG	900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9450	NA
374	e3ca9046-9634-4332-b19f-88b18110f941	TCGA.CM.4751	TCGA-CM-4751-D16812	38f342e3-3027-4015-9bd8-e32b4147942b	2011-9-26	OXALIPLATIN	NA	CHEMOTHERAPY	54	FALSE	208	NA	NA	NA	NA	12	NA	MG	MG	150	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1950	NA
375	2d3ce817-b269-4662-a92d-392bd3662399	TCGA.CM.5341	TCGA-CM-5341-D5927	a7fd2c6d-39f7-4b7a-a2a0-1c7922e5fb77	2011-1-10	FLUOROURACIL	NA	CHEMOTHERAPY	122	FALSE	273	NA	NA	NA	NA	11	NA	MG	MG	600	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5900	NA
376	2d3ce817-b269-4662-a92d-392bd3662399	TCGA.CM.5341	TCGA-CM-5341-D16156	929311bf-d001-4c25-8554-b7e6d5bb7f98	2011-9-14	FLUOROURACIL	NA	CHEMOTHERAPY	122	FALSE	273	NA	NA	NA	NA	11	NA	MG	MG	1700	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	16600	NA
377	2d3ce817-b269-4662-a92d-392bd3662399	TCGA.CM.5341	TCGA-CM-5341-D16157	516885c2-a0e5-4bd5-ad56-d9d59a1c9a8a	2011-9-14	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	122	FALSE	273	NA	NA	NA	NA	11	ANCILLARY	MG	MG	600	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4580	NA
378	b6202d8d-dd3c-4fa2-9242-6e55759846af	TCGA.CM.5344	TCGA-CM-5344-D15261	82888328-8e75-4806-a3b5-fa5170d5a665	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	68	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	650	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7800	NA
379	b6202d8d-dd3c-4fa2-9242-6e55759846af	TCGA.CM.5344	TCGA-CM-5344-D15264	a3bae552-da95-42e8-b17c-c73532e66b4d	2011-8-15	PEGFILGRASTIM (PEG G-CSF)	NA	OTHER, SPECIFY IN NOTES	91	FALSE	217	NA	NA	NA	NA	10	ANCILLARY AGENT	MG	MG	6	1	SUBCUTANEOUS	NA	NA	ADJUVANT	NA	60	NA
380	b6202d8d-dd3c-4fa2-9242-6e55759846af	TCGA.CM.5344	TCGA-CM-5344-D15263	c73bd755-af7e-413c-8d7d-ccd715806859	2011-8-15	FILGRASTIM (G-CSF)	NA	OTHER, SPECIFY IN NOTES	81	FALSE	81	NA	NA	NA	NA	1	ANCILLARY AGENT	UG	UG	300	1	SUBCUTANEOUS	NA	NA	ADJUVANT	NA	300	NA
381	b6202d8d-dd3c-4fa2-9242-6e55759846af	TCGA.CM.5344	TCGA-CM-5344-D15259	06418df1-95ee-4f7e-ac89-3b3af2d0490a	2011-8-15	OXALIPLATIN	NA	CHEMOTHERAPY	68	FALSE	215	NA	NA	NA	NA	11	NA	MG	MG	140	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1540	NA
382	b6202d8d-dd3c-4fa2-9242-6e55759846af	TCGA.CM.5344	TCGA-CM-5344-D15262	d4db4d65-33e4-4814-99eb-8354ca36eeca	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	68	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	2000	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	23900	NA
383	b6202d8d-dd3c-4fa2-9242-6e55759846af	TCGA.CM.5344	TCGA-CM-5344-D15260	983af547-6cba-4e7d-a1c7-2ca7836f519c	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	68	FALSE	229	NA	NA	NA	NA	12	ANCILLARY AGENT	MG	MG	650	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	6340	NA
384	96e013d9-8e89-46a7-8d07-bae95af36708	TCGA.CM.5860	TCGA-CM-5860-D15254	4ba86384-0a23-4be8-8325-35f6d8b205df	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	57	FALSE	211	NA	NA	NA	NA	12	ANCILLARY AGENT	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7680	NA
385	96e013d9-8e89-46a7-8d07-bae95af36708	TCGA.CM.5860	TCGA-CM-5860-D15257	adf45a83-5b88-431b-b19c-a7c9ef785048	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	57	FALSE	211	NA	NA	NA	NA	12	NA	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9800	NA
386	96e013d9-8e89-46a7-8d07-bae95af36708	TCGA.CM.5860	TCGA-CM-5860-D15253	615d6a0c-5eb5-45db-9971-0001fd1f9cd8	2011-8-15	OXALIPLATIN	NA	CHEMOTHERAPY	57	FALSE	197	NA	NA	NA	NA	11	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1940	NA
387	96e013d9-8e89-46a7-8d07-bae95af36708	TCGA.CM.5860	TCGA-CM-5860-D15258	a83b56b5-b668-4477-b60c-6df4812fea50	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	57	FALSE	211	NA	NA	NA	NA	12	NA	MG	MG	2602.17	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	30402.17	NA
388	cc1d6ad3-b60d-482e-8fa4-0af26823007d	TCGA.CM.5863	TCGA-CM-5863-D17065	93087750-78fd-430a-9c55-be528ae2e4bb	2011-9-30	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	86	FALSE	240	NA	NA	NA	NA	12	ANCILLARY	MG	MG	650	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	5000	NA
389	cc1d6ad3-b60d-482e-8fa4-0af26823007d	TCGA.CM.5863	TCGA-CM-5863-D17064	999f4791-5483-46b6-b0e8-cec6ba836469	2011-9-30	FLUOROURACIL	NA	CHEMOTHERAPY	86	FALSE	240	NA	NA	NA	NA	12	NA	MG	MG	1900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	21800	NA
390	cc1d6ad3-b60d-482e-8fa4-0af26823007d	TCGA.CM.5863	TCGA-CM-5863-D17066	8419859d-441b-466d-9c75-b60790d0a64b	2011-9-30	OXALIPLATIN	NA	CHEMOTHERAPY	86	FALSE	240	NA	NA	NA	NA	12	NA	MG	MG	140	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1510	NA
391	cc1d6ad3-b60d-482e-8fa4-0af26823007d	TCGA.CM.5863	TCGA-CM-5863-D17068	8ed1a0ab-3763-46c2-9f61-21677b677973	2011-9-30	PEGFILGRASTIM	NA	OTHER, SPECIFY IN NOTES	229	FALSE	229	NA	NA	NA	NA	1	ANCILLARY	MG	MG	6	1	SUBCUTANEOUS	NA	NA	ADJUVANT	NA	6	NA
392	cc1d6ad3-b60d-482e-8fa4-0af26823007d	TCGA.CM.5863	TCGA-CM-5863-D17062	2e32a9b2-feed-4616-84aa-8c1d6ca8acd6	2011-9-30	FLUOROURACIL	NA	CHEMOTHERAPY	86	FALSE	240	NA	NA	NA	NA	12	NA	MG	MG	650	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7450	NA
393	4aadf2a2-ce1e-4f94-b146-59292e83e7fd	TCGA.CM.5868	TCGA-CM-5868-D15265	231ad9ed-6fbf-41e0-b7f6-f37b39bfe7c6	2011-8-15	FLOXURIDINE	NA	CHEMOTHERAPY	31	TRUE	NA	NA	NA	NA	NA	9	NA	MG	MG	290	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1084	NA
394	4aadf2a2-ce1e-4f94-b146-59292e83e7fd	TCGA.CM.5868	TCGA-CM-5868-D15270	e1b8376b-e4a5-40b0-aa12-f2f19ef1d26a	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	316	TRUE	NA	NA	NA	NA	NA	2	NA	MG	MG	2200	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4400	NA
395	4aadf2a2-ce1e-4f94-b146-59292e83e7fd	TCGA.CM.5868	TCGA-CM-5868-D15268	4f3182e8-b6a8-4457-b4c7-719105d866d1	2011-8-15	DEXAMETHASONE	NA	OTHER, SPECIFY IN NOTES	78	TRUE	NA	NA	NA	NA	NA	2	ANCILLARY AGENT	MG	MG	25	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	40	NA
396	4aadf2a2-ce1e-4f94-b146-59292e83e7fd	TCGA.CM.5868	TCGA-CM-5868-D15266	91d3a944-24bc-4e79-9a0b-bcd64ee991b2	2011-8-15	OXALIPLATIN	NA	CHEMOTHERAPY	45	TRUE	NA	NA	NA	NA	NA	9	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1100	NA
397	4aadf2a2-ce1e-4f94-b146-59292e83e7fd	TCGA.CM.5868	TCGA-CM-5868-D15267	1071fb4b-8369-4469-8f2b-3263a3bd1f05	2011-8-15	IRINOTECAN HCL	NA	CHEMOTHERAPY	45	TRUE	NA	NA	NA	NA	NA	20	NA	MG	MG	260	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4160	NA
398	4aadf2a2-ce1e-4f94-b146-59292e83e7fd	TCGA.CM.5868	TCGA-CM-5868-D15269	45dc93fc-8988-4181-bd98-c69db74aef7a	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	316	TRUE	NA	NA	NA	NA	NA	2	ANCILLARY AGENT	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1700	NA
399	ec3f3f11-75df-4fcc-ba03-f19aca907645	TCGA.CM.6162	TCGA-CM-6162-D15247	e7fcc21e-a928-4e42-a8ea-b0e4c41801be	2011-8-15	OXALIPLATIN	NA	CHEMOTHERAPY	86	FALSE	240	NA	NA	NA	NA	12	NA	MG	MG	190	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	2220	NA
400	ec3f3f11-75df-4fcc-ba03-f19aca907645	TCGA.CM.6162	TCGA-CM-6162-D15250	d84d0e07-d035-423a-8c82-89b97d740df7	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	86	FALSE	240	NA	NA	NA	NA	12	ANCILLARY AGENT	MG	MG	900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7980	NA
401	ec3f3f11-75df-4fcc-ba03-f19aca907645	TCGA.CM.6162	TCGA-CM-6162-D15252	d1f5f997-c18a-4c1a-a070-423e4d0edcc0	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	86	FALSE	240	NA	NA	NA	NA	12	NA	MG	MG	2700	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	31600	NA
402	ec3f3f11-75df-4fcc-ba03-f19aca907645	TCGA.CM.6162	TCGA-CM-6162-D15251	22258b34-c867-40d2-86f5-1c577600455d	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	86	FALSE	240	NA	NA	NA	NA	12	NA	MG	MG	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10500	NA
403	8e87ddca-f43e-4c6f-9d5b-430b666a7f6c	TCGA.CM.6169	TCGA-CM-6169-D15236	7997d2ef-1c60-43b9-9096-e0c4fe13dea2	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	89	FALSE	243	NA	NA	NA	NA	12	ANCILLARY AGENT	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7050	NA
404	8e87ddca-f43e-4c6f-9d5b-430b666a7f6c	TCGA.CM.6169	TCGA-CM-6169-D15238	11bdf997-2b4c-4fd3-a358-3621721d4fa8	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	89	FALSE	243	NA	NA	NA	NA	12	NA	MG	MG	850	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10200	NA
405	8e87ddca-f43e-4c6f-9d5b-430b666a7f6c	TCGA.CM.6169	TCGA-CM-6169-D15215	d843573b-abb6-4375-b320-65b6e417f688	2011-8-15	OXALIPLATIN	NA	CHEMOTHERAPY	89	FALSE	159	NA	NA	NA	NA	6	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1080	NA
406	8e87ddca-f43e-4c6f-9d5b-430b666a7f6c	TCGA.CM.6169	TCGA-CM-6169-D15240	bcc4b8af-2a42-4ea6-b631-67417436a9e2	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	89	FALSE	243	NA	NA	NA	NA	12	NA	MG	MG	2600	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	31200	NA
407	40c217ee-429f-41f4-adc6-db9186622b17	TCGA.CM.6172	TCGA-CM-6172-D15211	fede8ba2-c2c4-4f42-93f9-5599ab87d56d	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	89	FALSE	245	NA	NA	NA	NA	12	NA	MG	MG	2100	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	24000	NA
408	40c217ee-429f-41f4-adc6-db9186622b17	TCGA.CM.6172	TCGA-CM-6172-D15210	4ab077b9-0d4a-4eba-91a6-afb6b7dea381	2011-8-15	FLUOROURACIL	NA	CHEMOTHERAPY	89	FALSE	245	NA	NA	NA	NA	12	NA	MG	MG	700	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	7950	NA
409	40c217ee-429f-41f4-adc6-db9186622b17	TCGA.CM.6172	TCGA-CM-6172-D15207	1c92cd0a-a3ad-417d-b9f2-5ee194656f03	2011-8-15	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	89	FALSE	245	NA	NA	NA	NA	12	ANCILLARY AGENT	MG	MG	700	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	6890	NA
410	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D17053	95f85e67-bcf8-41f4-ab52-2987bb657f7f	2011-4-19	FLUOROURACIL	NA	CHEMOTHERAPY	24	FALSE	184	NA	NA	NA	NA	12	NA	MG	MG	2800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	32600	NA
411	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D17055	7ca01e01-187e-4151-8bb8-ce64a784aa3b	2011-4-19	LEUCOVORIN CALCIUM	NA	OTHER, SPECIFY IN NOTES	24	FALSE	184	NA	NA	NA	NA	12	ANCILLARY	MG	MG	900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9400	NA
412	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D17056	561e1b28-4f4f-4a49-ac98-773ff5f37469	2011-9-30	OXALIPLATIN	NA	CHEMOTHERAPY	24	FALSE	150	NA	NA	NA	NA	10	NA	MG	MG	190	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1780	NA
413	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D17058	c2e7d5c5-7b1f-4a5c-9df4-a5a48969c93c	2011-9-30	PEGFILGRASTIM	NA	OTHER, SPECIFY IN NOTES	54	FALSE	152	NA	NA	NA	NA	7	ANCILLARY	MG	MG	6	1	SUBCUTANEOUS	NA	NA	ADJUVANT	NA	42	NA
414	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D30935	d1a17bb6-9a68-4c16-9360-01cd3518b8d4	2012-4-19	FLUOROURACIL	NA	CHEMOTHERAPY	337	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
415	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D30939	e3a83403-6a75-451b-a0e6-0cbd8e0635a8	2012-4-19	IRINOTECAN HCL	NA	CHEMOTHERAPY	337	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
416	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D30940	e24f390b-4610-43a6-8399-34d5373fb519	2012-4-19	LEUCOVORIN CALCIUM	NA	CHEMOTHERAPY	337	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
417	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D30942	a3363539-73b2-432d-aaaa-e0638f2cc5df	2012-4-19	CETUXIMAB	NA	CHEMOTHERAPY	366	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
418	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D30943	63a50739-dc5b-40cd-90f2-b709c14dfde0	2012-4-19	FLOXURIDINE	NA	CHEMOTHERAPY	337	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
419	fce1fd5a-54d2-4260-b187-4eb7035e96e9	TCGA.CM.6675	TCGA-CM-6675-D17052	c2c0fc72-b0b4-41c1-83bf-df641b19a714	2012-4-19	FLUOROURACIL	NA	CHEMOTHERAPY	24	FALSE	178	NA	NA	NA	NA	12	NA	MG	MG	900	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9400	NA
420	d7048098-09b3-4763-ad54-9c5c6fe14bc0	TCGA.CM.6678	TCGA-CM-6678-D30951	e903ec03-d66a-4f5b-87a8-e1e78e0e79e6	2012-4-19	FLOXURIDINE	NA	CHEMOTHERAPY	275	FALSE	275	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
421	d7048098-09b3-4763-ad54-9c5c6fe14bc0	TCGA.CM.6678	TCGA-CM-6678-D30953	fbd5870c-73a8-401f-a792-4a7aeda61922	2012-4-19	IRINOTECAN HCL	NA	CHEMOTHERAPY	275	FALSE	306	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
422	d7048098-09b3-4763-ad54-9c5c6fe14bc0	TCGA.CM.6678	TCGA-CM-6678-D17051	f1e0900b-3a55-4d01-b8ed-d23892afb723	2012-4-19	IRINOTECAN HCL	NA	CHEMOTHERAPY	17	FALSE	214	NA	NA	NA	NA	12	NA	MG	MG	200	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	2040	NA
423	d7048098-09b3-4763-ad54-9c5c6fe14bc0	TCGA.CM.6678	TCGA-CM-6678-D17049	01518ad8-5c28-40d7-8e5f-2d15a4df5355	2012-4-19	FLOXURIDINE	NA	CHEMOTHERAPY	0	FALSE	214	NA	NA	NA	NA	7	NA	MG	MG	170	1	INHALATION	NA	NA	ADJUVANT	NA	475	NA
424	d7048098-09b3-4763-ad54-9c5c6fe14bc0	TCGA.CM.6678	TCGA-CM-6678-D17050	0452e18b-530a-40c8-bd25-d973c1784af8	2012-4-19	OXALIPLATIN	NA	CHEMOTHERAPY	30	FALSE	91	NA	NA	NA	NA	7	NA	MG	MG	130	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	770	NA
425	0dacc5ce-498f-4c60-9f78-7a013ffaa9ce	TCGA.D5.5538	TCGA-D5-5538-D13828	20ccac76-619d-4720-a197-8a648eb7ef26	2011-6-20	CALCIUM FOLIATUM, FLUOROURACILUM, OXALIPLATINUM, DEXAMETHASSONE	NA	CHEMOTHERAPY	22	FALSE	282	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
426	15d1b0fb-5c5f-4689-94f5-b33120a2bfae	TCGA.D5.5539	TCGA-D5-5539-D20730	cfa250cc-1c8d-4e9f-8385-fe6426cd2c8c	2012-1-19	5-FU	NA	CHEMOTHERAPY	38	FALSE	195	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
427	94067eb7-98b7-4975-bab1-c09e1b454a25	TCGA.D5.5541	TCGA-D5-5541-D13833	a81be0b5-fa86-4b78-91df-05546d47d69c	2011-7-4	CALCIUM FOLIATUM, FLUOROURACILUM, OXALIPLATINUM, DEXAMETHASSONE	NA	CHEMOTHERAPY	19	FALSE	279	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
428	9c34830b-4d7f-4b41-9659-fbfc36c145c9	TCGA.D5.6529	TCGA-D5-6529-D28929	8f6e7fb1-f1f1-4c84-a677-d71f8713a584	2012-3-2	OXALIPLATINUM+ 5-FU	NA	CHEMOTHERAPY	502	TRUE	NA	NA	NA	NA	NA	9	NA	NA	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
429	fa83dfb5-7386-4a35-9861-aa866478d5f1	TCGA.D5.6533	TCGA-D5-6533-D34457	752BD87B-FBD0-4A45-AA82-C60FF3B4B3F3	2012-8-15	OXALIPLATIN, FOLINIC ACID, FLUOROURACIL	NA	CHEMOTHERAPY	67	FALSE	195	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
430	e83e5700-f968-4978-bb78-56a83936ce8c	TCGA.D5.6536	TCGA-D5-6536-D28926	16cf1090-853e-4a5c-8ba5-6eb873d29def	2012-2-3	5-FU	NA	CHEMOTHERAPY	539	TRUE	NA	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG	425	NA	INTRAVENOUS	NA	NA	PALLIATIVE	NA	3750	NA
431	a117ace8-ac5a-48d8-8aee-3024d6f0f873	TCGA.D5.6538	TCGA-D5-6538-D28625	fe993031-2966-48c0-af72-b6e31f2652ec	2012-2-27	XELODA	NA	CHEMOTHERAPY	23	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
432	3a8ca50f-bc9f-4250-8c8d-22893763ea46	TCGA.D5.6926	TCGA-D5-6926-D29710	b896f753-4ea9-43d6-a893-529e05927fbb	2012-3-28	5-FLUOROURACIL + LEUCOVORIN	NA	CHEMOTHERAPY	42	FALSE	196	NA	NA	NA	NA	6	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
433	64b0461f-038d-4712-948e-818dc2f10eef	TCGA.D5.6929	TCGA-D5-6929-D29898	5EED9D54-58D8-44C3-ADFA-E95A41C3B1D7	2012-3-30	OXALIPLATINUM+5 FLUOROURACILUM	NA	CHEMOTHERAPY	48	FALSE	216	NA	NA	NA	NA	NA	NA	MG/M2	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
434	b823d6e5-54b0-43d3-95e2-9be33dc6f734	TCGA.DM.A0XF	TCGA-DM-A0XF-D30352	85F76F5C-1C87-421C-AE2C-9346148FFA56	2012-4-10	MAYO 425-20	NA	CHEMOTHERAPY	45	FALSE	174	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
435	b823d6e5-54b0-43d3-95e2-9be33dc6f734	TCGA.DM.A0XF	TCGA-DM-A0XF-D30353	5A51E617-F6C8-4325-A8B3-8355D2A9C937	2012-4-12	FOLFIRI	NA	CHEMOTHERAPY	201	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
436	2a7bbafe-d499-4241-ba3d-a52ba0a5db3c	TCGA.F4.6460	TCGA-F4-6460-D29827	E00AA1AF-9E7F-47DD-BA9D-3662DCE2FD87	2012-3-29	OXALIPLATIN	NA	CHEMOTHERAPY	26	FALSE	138	NA	NA	NA	NA	6	NA	MG/DAY	MG	150	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	900	NA
437	2a7bbafe-d499-4241-ba3d-a52ba0a5db3c	TCGA.F4.6460	TCGA-F4-6460-D29828	DE75E343-2A6A-4264-A2B7-1F99A217E0C7	2012-3-29	RALTITREXED	NA	CHEMOTHERAPY	313	TRUE	NA	NA	NA	NA	NA	5	NA	G/DAY	NA	4	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	20	NA
438	2a7bbafe-d499-4241-ba3d-a52ba0a5db3c	TCGA.F4.6460	TCGA-F4-6460-D29825	24A4BE6E-8504-46A7-9FE6-9F601A1E0AAA	2012-3-29	CAPECITABINE	NA	CHEMOTHERAPY	26	FALSE	229	NA	NA	NA	NA	10	NA	G/DAY	G/DAY	4	NA	ORAL	NA	NA	ADJUVANT	NA	640	NA
439	d3062aac-4c42-41b4-a9f3-90aa72e6fb1e	TCGA.F4.6569	TCGA-F4-6569-D63479	07B6950E-FF2F-4B33-BFF0-9CB598F7EFE2	2014-8-11	LEUCOVORIN	NA	ANCILLARY	23	FALSE	201	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
440	d3062aac-4c42-41b4-a9f3-90aa72e6fb1e	TCGA.F4.6569	TCGA-F4-6569-D63480	6AC4AB3C-AA5A-4D66-B031-2ED464C10E17	2014-8-11	5-FLUOROURACIL	NA	CHEMOTHERAPY	23	FALSE	201	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
441	e76258b7-e13a-4b05-855b-d792701ffba1	TCGA.F4.6805	TCGA-F4-6805-D35065	8EEA3753-54B7-4A29-9F52-588A974F7AA9	2012-9-14	XELODA	NA	CHEMOTHERAPY	29	FALSE	111	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
442	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35434	21322B68-CA4A-4EBD-B6C2-2DE312E8C191	2012-9-27	IRINOTECAN	NA	CHEMOTHERAPY	42	FALSE	158	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
443	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35435	CE89B929-B40D-4B1D-8F2A-17FA387A40C0	2012-9-27	LEUCOVORIN	NA	ANCILLARY	42	FALSE	158	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
444	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35436	C8070FFD-ED9D-4F92-8CC9-CDA03C1EF7FF	2012-9-27	5-FLUOROURACIL	NA	CHEMOTHERAPY	42	FALSE	158	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
445	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35438	DB534232-0D51-49A2-8358-24D5BBA3A286	2012-9-27	MITOMYCIN	NA	CHEMOTHERAPY	173	FALSE	263	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
446	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35439	3CC4372C-CC95-4B06-B228-9917C5A2C310	2012-9-27	CAPECITABINE	NA	CHEMOTHERAPY	173	FALSE	263	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
447	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35440	270B1EAE-76FD-4BA8-82A9-61109D1AC48E	2012-9-27	OXALIPLATIN	NA	CHEMOTHERAPY	361	FALSE	412	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
448	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D35441	039AEB96-42C2-4F56-B70A-9C5F9D2CA39F	2012-9-27	CAPECITABINE	NA	CHEMOTHERAPY	361	FALSE	412	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
449	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D55585	2843DF68-7A05-4F45-A0BD-415396178241	2014-1-9	OXALIPLATIN	NA	CHEMOTHERAPY	641	FALSE	760	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
450	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D55586	4A462DE8-23F3-43E1-B382-753F79648D56	2014-1-9	LEUCOVORIN	NA	ANCILLARY	641	FALSE	760	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
451	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D55587	8FBAFE5C-1DDC-4C8A-B9B1-1EE6000053B5	2014-1-9	CAMPTOSAR	NA	CHEMOTHERAPY	641	FALSE	760	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
452	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D55588	0457213A-4DDB-44D8-BAC8-B2125E5CD62C	2014-1-9	5-FLUOROURACIL	NA	CHEMOTHERAPY	641	FALSE	760	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
453	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D55589	870532C3-7644-44F2-A51B-2B95044B6D5D	2014-1-9	AVASTIN	NA	CHEMOTHERAPY	760	FALSE	883	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
454	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D65811	E22F95B8-5CCA-448B-AD4B-39064F0FBC9E	2014-9-30	OXALIPLATIN	NA	CHEMOTHERAPY	1161	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
455	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D65812	B08A4384-7260-4BC1-BFA8-BB1F06BC9A7C	2014-9-30	CAPECITABINE	NA	CHEMOTHERAPY	1161	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
456	bab21810-f51b-421e-a87f-1f1136cbc77a	TCGA.F4.6806	TCGA-F4-6806-D65813	3BAE1404-D8D7-407F-B349-E6868293CD6B	2014-9-30	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1161	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
457	9382987c-b5b3-48fe-8194-4d83fe340cd0	TCGA.F4.6807	TCGA-F4-6807-D35070	7599BE98-8FE6-4E14-A6BF-8F31624CF90F	2012-9-14	XELODA	NA	CHEMOTHERAPY	73	FALSE	284	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
458	64bd568d-0509-48fe-8d0a-aef2a85d5c57	TCGA.F4.6856	TCGA-F4-6856-D63483	033361EE-254A-46F4-99D4-61E8F52D027B	2014-8-11	LEUCOVORIN	NA	ANCILLARY	11	FALSE	41	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
459	64bd568d-0509-48fe-8d0a-aef2a85d5c57	TCGA.F4.6856	TCGA-F4-6856-D63488	62D6AB27-A225-4519-9D76-92ACDD34CADF	2014-8-11	5-FLUOROURACIL	NA	CHEMOTHERAPY	11	FALSE	41	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
460	27d9c162-11bb-48fb-a41a-aa05fcb4c1c2	TCGA.G4.6293	TCGA-G4-6293-D21800	b280e2a2-cbfb-45dd-9277-bb4a0c42f558	2012-1-19	FLUOROURACIL	NA	CHEMOTHERAPY	25	FALSE	235	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	500	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	2000	NA
461	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22046	fc42c0f1-55d8-42a0-8845-2934c2f3ec16	2012-2-21	ERBITUX	NA	CHEMOTHERAPY	699	FALSE	699	NA	NA	NA	NA	1	NA	NA	NA	NA	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
462	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22042	5a510a56-eb65-4936-9e48-2d8ecdb51c1f	2012-2-21	LEUCOVORIN	NA	CHEMOTHERAPY	535	FALSE	699	NA	NA	NA	NA	13	NA	NA	NA	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
463	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22045	1a072c20-b6cb-46c5-af5d-9dccfd8d1afb	2012-2-21	IRINOTECAN	NA	CHEMOTHERAPY	699	FALSE	699	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	125	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	125	NA
464	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22038	ae9c5e2a-c767-42b1-a16a-9c9f73074e4d	2012-2-21	LEUCOVORIN	NA	CHEMOTHERAPY	1	FALSE	349	NA	NA	NA	NA	20	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
465	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22047	96567c06-fd8b-432c-9b95-35f1c462b05c	2012-2-21	ERBITUX	NA	CHEMOTHERAPY	819	FALSE	846	NA	NA	NA	NA	4	NA	MG	MG	560	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	1610	NA
466	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22036	f5cb0992-8578-4bd2-ba86-8513ec065440	2012-2-21	AVASTIN	NA	CHEMOTHERAPY	1	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
467	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22041	0ea0145e-3a7d-40d6-b958-54abb60540af	2012-2-21	FLUOROURACIL	NA	CHEMOTHERAPY	1	FALSE	349	NA	NA	NA	NA	20	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
468	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22044	dcdccc6a-81a7-4b9d-bf04-6561175b1d1a	2012-2-21	OXALIPLATIN	NA	CHEMOTHERAPY	535	FALSE	699	NA	NA	NA	NA	13	NA	MG/M2	MG/M2	55	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	715	NA
469	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22043	4801f827-3069-49da-9725-5b242a26f836	2012-2-21	FLUOROURACIL	NA	CHEMOTHERAPY	535	FALSE	699	NA	NA	NA	NA	13	NA	NA	NA	NA	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
470	41f8c9fd-ae52-4458-886b-faf37de77dd0	TCGA.G4.6294	TCGA-G4-6294-D22039	7101e3e7-3beb-48f7-9c4e-8aeb5c76bc14	2012-2-21	OXALIPLATIN	NA	CHEMOTHERAPY	1	FALSE	349	NA	NA	NA	NA	20	NA	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
471	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22076	991cc478-d3ed-4616-beae-0cc297dd9613	2012-1-19	CETUXIMAB	NA	CHEMOTHERAPY	565	FALSE	726	NA	NA	NA	NA	23	NA	MG	MG	760	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	11210	NA
472	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22071	8425101a-756c-410d-81a8-2076b80de3bb	2012-1-19	OXALIPLATIN	NA	CHEMOTHERAPY	33	FALSE	103	NA	NA	NA	NA	NA	NA	MG/M2	NA	85	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
473	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22073	26aae8b9-b217-4ae4-84d2-20eb58eaa2b2	2012-1-19	FLUOROURACIL	NA	CHEMOTHERAPY	33	FALSE	103	NA	NA	NA	NA	NA	NA	MG/M2	NA	400	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
474	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22080	f0c7c99e-319d-4edb-b480-dd3e75e87b4e	2012-1-19	BEVACIZUMAB	NA	CHEMOTHERAPY	1041	FALSE	1181	NA	NA	NA	NA	10	NA	MG	MG	445	3	INTRAVENOUS	NA	NA	RECURRENCE	NA	4310	NA
475	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22079	c9ab9ffe-f904-4dfa-914c-0e8d4b3ed184	2012-1-19	IRINOTECAN	NA	CHEMOTHERAPY	565	FALSE	719	NA	NA	NA	NA	12	NA	MG	MG	342	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	4104	NA
476	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22093	99251907-ED41-4F3E-B4C8-B927812A6053	2012-1-19	IRINOTECAN	NA	CHEMOTHERAPY	1687	FALSE	2373	NA	NA	NA	NA	45	NA	MG	MG	300	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	13386	NA
477	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22084	f7189321-dcef-43c0-9505-44974a7d1aae	2012-1-19	FLUOROURACIL	NA	CHEMOTHERAPY	1041	FALSE	1181	NA	NA	NA	NA	10	NA	MG	MG	800	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	7900	NA
478	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22086	f780471b-7abe-465c-a68a-8cdc3c54bbf3	2012-1-19	LEUCOVORIN	NA	CHEMOTHERAPY	1041	FALSE	1181	NA	NA	NA	NA	10	NA	MG	MG	800	3	INTRAVENOUS	NA	NA	RECURRENCE	NA	7900	NA
479	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22068	bc52a962-29c2-4ed2-bea0-fe0240f2aca4	2012-1-19	AVASTIN	NA	CHEMOTHERAPY	33	FALSE	103	NA	NA	NA	NA	NA	NA	MG/KG	NA	5	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
480	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22089	D9C655DD-4834-48B8-92CE-1F9B3F354760	2012-1-19	XELODA	NA	CHEMOTHERAPY	1377	FALSE	1636	NA	NA	NA	NA	13	NA	MG/DAY	MG	3600	4	ORAL	NA	NA	PROGRESSION	NA	655200	NA
481	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22074	6ab9bc08-f684-4502-8451-741d5a9dbff9	2012-1-19	LEUCOVORIN	NA	CHEMOTHERAPY	33	FALSE	103	NA	NA	NA	NA	NA	NA	MG/M2	NA	400	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
482	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22087	25C9F9E7-35F7-4297-95CE-B9DAD4C1947F	2012-1-19	BEVACIZUMAB	NA	CHEMOTHERAPY	1377	TRUE	NA	NA	NA	NA	NA	61	NA	MG	MG	712	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	30661	NA
483	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22096	FEAAEA2D-1E20-4535-A045-B8681E6342A9	2012-1-19	OXALIPLATIN	NA	CHEMOTHERAPY	2450	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	168	6	INTRAVENOUS	NA	NA	PROGRESSION	NA	630	NA
484	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22082	2163c50a-6a57-4240-8eab-f6502f8bb1aa	2012-1-19	OXALIPLATIN	NA	CHEMOTHERAPY	1041	FALSE	1076	NA	NA	NA	NA	3	NA	MG	MG	170	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	510	NA
485	622cc1c4-d721-4b5c-a88b-216d6368660b	TCGA.G4.6297	TCGA-G4-6297-D22097	D3DB8174-2096-4232-874D-ED93B8C42CAE	2012-1-19	FLUOROURACIL	NA	CHEMOTHERAPY	2450	FALSE	2450	NA	NA	NA	NA	1	NA	MG	MG	792	6	INTRAVENOUS	NA	NA	PROGRESSION	NA	792	NA
486	ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1	TCGA.G4.6298	TCGA-G4-6298-D21967	4b271363-fb42-41fc-ba0a-4a1866ebd1d7	2012-1-20	ERBITUX	NA	CHEMOTHERAPY	412	FALSE	462	NA	NA	NA	NA	4	NA	MG	MG	440	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	1760	NA
487	ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1	TCGA.G4.6298	TCGA-G4-6298-D21968	b201fb4c-7422-447a-87c1-c46516ed2b91	2012-1-20	IRINOTECAN	NA	CHEMOTHERAPY	412	FALSE	462	NA	NA	NA	NA	4	NA	MG	MG	176	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	704	NA
488	23252dca-e836-47a0-b294-758ad60aa259	TCGA.G4.6299	TCGA-G4-6299-D22033	3a112e40-6f15-46f9-a153-7cf96e71c8f4	2012-1-20	FLUOROURACIL	NA	OTHER, SPECIFY IN NOTES	38	FALSE	192	NA	NA	NA	NA	12	PHASE III CLINICAL TRIAL	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
489	23252dca-e836-47a0-b294-758ad60aa259	TCGA.G4.6299	TCGA-G4-6299-D22029	f7f479e8-c97f-4318-841c-4093a7451dfc	2012-1-20	BEVACIZUMAB	NA	OTHER, SPECIFY IN NOTES	38	FALSE	363	NA	NA	NA	NA	24	PHASE III CLINICAL TRIAL	MG/KG	MG/KG	5	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	120	NA
490	23252dca-e836-47a0-b294-758ad60aa259	TCGA.G4.6299	TCGA-G4-6299-D22030	7c7ee768-9568-4ec4-9026-3ce737ed05dc	2012-1-20	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	38	FALSE	192	NA	NA	NA	NA	12	PHASE III CLINICAL TRIAL	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
491	23252dca-e836-47a0-b294-758ad60aa259	TCGA.G4.6299	TCGA-G4-6299-D22032	cdfa4fa2-4682-4fc8-883a-185c52a8986d	2012-1-20	OXALIPLATIN	NA	OTHER, SPECIFY IN NOTES	38	FALSE	192	NA	NA	NA	NA	12	PHASE III CLINICAL TRIAL	NA	NA	NA	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
492	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21722	8513635f-8463-49de-83f2-6c54d479b728	2012-1-23	5-FU	NA	CHEMOTHERAPY	1443	FALSE	1596	NA	NA	NA	NA	NA	NA	NA	NA	NA	3	NA	NA	NA	PROGRESSION	NA	NA	NA
493	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21725	b33e676e-a8c1-4fa6-9015-db6d44507b9d	2012-1-23	ERBITUX	NA	CHEMOTHERAPY	1596	FALSE	1838	NA	NA	NA	NA	12	NA	NA	NA	NA	4	NA	NA	NA	PROGRESSION	NA	NA	NA
494	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21793	57D9E884-76A1-4676-9427-18237D676857	2012-1-23	LEUCOVORIN	NA	CHEMOTHERAPY	1840	FALSE	1994	NA	NA	NA	NA	10	NA	MG	MG	680	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	6790	NA
495	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21604	469d1453-719a-4bec-bf80-abd497cca359	2012-1-23	LEUCOVORIN	NA	CHEMOTHERAPY	896	FALSE	1443	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	NA	PROGRESSION	NA	NA	NA
496	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21794	5CEB94A7-D009-4796-A6B3-E5D560CC9B81	2012-1-23	5-FU	NA	CHEMOTHERAPY	1840	FALSE	1994	NA	NA	NA	NA	10	NA	NA	NA	NA	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
497	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21727	d26c7bb7-87f7-4960-9ed4-8ef58ac71e95	2012-1-23	IRINOTECAN	NA	CHEMOTHERAPY	1596	FALSE	1838	NA	NA	NA	NA	12	NA	NA	NA	NA	4	NA	NA	NA	PROGRESSION	NA	NA	NA
498	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21720	fa5d0604-06c3-454e-9925-da7bf7285324	2012-1-23	IRINOTECAN	NA	CHEMOTHERAPY	1443	FALSE	1596	NA	NA	NA	NA	NA	NA	NA	NA	NA	3	NA	NA	NA	PROGRESSION	NA	NA	NA
499	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21601	fbdd2907-7af7-4844-b7e9-b01ee80daa88	2012-1-23	OXALIPLATIN	NA	CHEMOTHERAPY	516	FALSE	682	NA	NA	NA	NA	6	NA	MG	MG	165	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	990	NA
500	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21602	d5338126-8849-4359-bd0e-9639362668d3	2012-1-23	5-FU	NA	CHEMOTHERAPY	516	FALSE	682	NA	NA	NA	NA	6	NA	MG	MG	660	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	3960	NA
501	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21603	57970f69-f63f-427e-bf68-86d90b0f5ac8	2012-1-23	AVASTIN	NA	CHEMOTHERAPY	896	FALSE	1443	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	NA	PROGRESSION	NA	NA	NA
502	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21789	c92c9a04-8347-4909-960b-0f4878f27b08	2012-1-23	OXALIPLATIN	NA	CHEMOTHERAPY	1840	FALSE	1994	NA	NA	NA	NA	10	NA	MG	MG	145	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	1450	NA
503	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21605	7a35095d-25fa-4780-95aa-88c2c4032d95	2012-1-23	5-FU	NA	CHEMOTHERAPY	896	FALSE	1443	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	NA	PROGRESSION	NA	NA	NA
504	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21600	30f4a7a0-2e8d-4001-b5ff-cc4797c7fd66	2012-1-23	LEUCOVORIN	NA	CHEMOTHERAPY	516	FALSE	682	NA	NA	NA	NA	6	NA	MG	MG	660	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	3960	NA
505	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21790	8D7F0299-6CC1-4878-AD8D-EFDA900B42D1	2012-1-23	BEVACIZUMAB	NA	CHEMOTHERAPY	1840	FALSE	1994	NA	NA	NA	NA	10	NA	MG	MG	325	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	3240	NA
506	264c0d45-078a-4207-a101-71f99bcd237e	TCGA.G4.6303	TCGA-G4-6303-D21717	34bd5fb4-ebfa-4d5b-9ae9-96be74c05bf1	2012-1-23	LEUCOVORIN	NA	CHEMOTHERAPY	1443	FALSE	1596	NA	NA	NA	NA	NA	NA	NA	NA	NA	3	NA	NA	NA	PROGRESSION	NA	NA	NA
507	567ddc8e-2b00-417d-a326-479cb02e08dd	TCGA.G4.6304	TCGA-G4-6304-D21879	acd0a481-2c9c-4f44-8241-5c356396a8e8	2012-2-6	LEUCOVORIN	NA	CHEMOTHERAPY	46	FALSE	258	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	ADJUVANT	NA	NA	NA
508	567ddc8e-2b00-417d-a326-479cb02e08dd	TCGA.G4.6304	TCGA-G4-6304-D21873	dd809433-8215-46dc-84c1-61087ef5c99b	2012-2-6	FLUOROURACIL	NA	CHEMOTHERAPY	46	FALSE	258	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	ADJUVANT	NA	NA	NA
509	567ddc8e-2b00-417d-a326-479cb02e08dd	TCGA.G4.6304	TCGA-G4-6304-D21877	3ebc93a4-f712-4cce-bf92-ac8e144d6365	2012-2-6	OXALIPLATIN	NA	CHEMOTHERAPY	46	FALSE	258	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	ADJUVANT	NA	NA	NA
510	568dbda7-88b5-4330-881f-dc5d6c7ce4ae	TCGA.G4.6307	TCGA-G4-6307-D21942	716a76ab-cae0-4593-820b-39fdc2d598d4	2012-1-25	OXALIPLATIN	NA	CHEMOTHERAPY	47	FALSE	187	NA	NA	NA	NA	8	NA	MG	MG	153	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1056	NA
511	568dbda7-88b5-4330-881f-dc5d6c7ce4ae	TCGA.G4.6307	TCGA-G4-6307-D21941	bcf0997e-092d-4457-9be6-90cb82e51bd4	2012-1-25	FLUOROURACIL	NA	CHEMOTHERAPY	47	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	720	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	8640	NA
512	568dbda7-88b5-4330-881f-dc5d6c7ce4ae	TCGA.G4.6307	TCGA-G4-6307-D21943	14d134ef-0304-4361-99b3-d74891f94c8a	2012-1-25	LEUCOVORIN	NA	CHEMOTHERAPY	47	FALSE	229	NA	NA	NA	NA	12	NA	MG	MG	720	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	8640	NA
513	e4be17c8-0855-432c-bb80-28bb24b62f32	TCGA.G4.6309	TCGA-G4-6309-D21947	0104d92b-90fe-42c8-9f02-dd916ce7b46f	2012-2-6	XELODA	NA	CHEMOTHERAPY	73	FALSE	254	NA	NA	NA	NA	8	NA	MG/DAY	MG	3600	1	ORAL	NA	NA	ADJUVANT	NA	355600	NA
514	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21937	7648d80e-9205-4675-b34d-f82fa7ab36a7	2012-1-25	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	153	FALSE	194	NA	NA	NA	NA	4	ANCILLARY	MG	MG	800	3	INTRAVENOUS	NA	NA	ADJUVANT	NA	3200	NA
515	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21928	cb1310c0-860e-4d70-a72e-96e0fdc38613	2012-1-25	OXALIPLATIN	NA	CHEMOTHERAPY	34	FALSE	76	NA	NA	NA	NA	4	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	684	NA
516	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21935	5e979430-9982-4b1b-8485-4805ba371049	2012-1-25	XELODA	NA	CHEMOTHERAPY	90	FALSE	132	NA	NA	NA	NA	NA	NA	MG/DAY	MG	3000	2	ORAL	NA	NA	ADJUVANT	NA	90000	NA
517	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21938	477f4c3c-ef6e-4873-9d95-3b1aa1e0d9a9	2012-1-25	5-FU	NA	CHEMOTHERAPY	153	FALSE	194	NA	NA	NA	NA	4	NA	NA	NA	NA	3	NA	NA	NA	ADJUVANT	NA	NA	NA
518	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21934	ced5bc62-7f2c-48e6-b830-f6f4a131fb03	2012-1-25	5-FU	NA	CHEMOTHERAPY	34	FALSE	76	NA	NA	NA	NA	4	NA	NA	NA	NA	1	NA	NA	NA	ADJUVANT	NA	NA	NA
519	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21936	1b57d686-2c1f-43ea-a842-1360b246b826	2012-1-25	OXALIPLATIN	NA	CHEMOTHERAPY	153	FALSE	194	NA	NA	NA	NA	4	NA	MG	MG	170	3	INTRAVENOUS	NA	NA	ADJUVANT	NA	680	NA
520	14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA.G4.6310	TCGA-G4-6310-D21933	892163e8-62fc-4fbe-a0ed-712508e46f84	2012-1-25	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	34	FALSE	76	NA	NA	NA	NA	4	ANCILLARY	MG	MG	840	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3200	NA
521	79d33c28-a7e2-4fca-8be1-a16fb6d68d49	TCGA.G4.6311	TCGA-G4-6311-D21921	47dfca4c-93b9-421c-be8f-617d251452ae	2012-1-27	OXALIPLATIN	NA	CHEMOTHERAPY	36	FALSE	148	NA	NA	NA	NA	9	NA	MG	MG	152	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1369	NA
522	79d33c28-a7e2-4fca-8be1-a16fb6d68d49	TCGA.G4.6311	TCGA-G4-6311-D21923	1e9c5fe9-4666-4187-ab0c-6c2b09dc240a	2012-1-27	LEUCOVORIN	NA	CHEMOTHERAPY	36	FALSE	190	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	400	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4800	NA
523	79d33c28-a7e2-4fca-8be1-a16fb6d68d49	TCGA.G4.6311	TCGA-G4-6311-D21922	f10cb485-4558-454a-9a1e-905a5cabba57	2012-1-27	FLUOROURACIL	NA	CHEMOTHERAPY	36	FALSE	190	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	400	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4800	NA
524	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21813	d2536ed5-5f4a-4cda-a592-2ff4aac998f2	2012-2-9	OXALIPLATIN	NA	CHEMOTHERAPY	48	FALSE	181	NA	NA	NA	NA	10	NA	MG	MG	160	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1577	NA
525	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21815	7e1069d3-9265-49bc-a9dd-2004971ed7bb	2012-2-9	BEVACIZUMAB	NA	CHEMOTHERAPY	337	FALSE	561	NA	NA	NA	NA	17	NA	MG	MG	386	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	6404	NA
526	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21822	1b0ba903-4ca7-483f-bf97-9e3138b7afdc	2012-2-9	IRINOTECAN	NA	CHEMOTHERAPY	954	FALSE	1045	NA	NA	NA	NA	7	NA	MG	MG	165	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	1085	NA
527	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21814	e59c220a-3767-418d-a106-a86a8ac11057	2012-2-9	FLUOROURACIL	NA	CHEMOTHERAPY	103	FALSE	209	NA	NA	NA	NA	8	NA	MG	MG	752	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	6000	NA
528	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21817	cf59cdd0-7a94-4432-90cf-15a5b6c41bc2	2012-2-9	LEUCOVORIN	NA	CHEMOTHERAPY	337	FALSE	561	NA	NA	NA	NA	17	NA	MG	MG	740	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	12464	NA
529	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21810	17ca7309-e359-4399-9b2f-67b7fbe11468	2012-2-9	LEUCOVORIN	NA	CHEMOTHERAPY	48	FALSE	209	NA	NA	NA	NA	12	NA	MG	MG	756	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	8976	NA
530	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21819	25e50ae8-9511-4f12-b1c4-73a2e8b2b2cc	2012-2-9	IRINOTECAN	NA	CHEMOTHERAPY	337	FALSE	561	NA	NA	NA	NA	17	NA	MG	MG	240	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	3874	NA
531	abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA.G4.6314	TCGA-G4-6314-D21821	6b644f7b-34e8-4860-ab40-d199dd3202cd	2012-2-9	CETUXIMAB	NA	CHEMOTHERAPY	954	FALSE	1045	NA	NA	NA	NA	7	NA	MG	MG	825	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	5765	NA
532	ca5b878f-8bff-410a-8e6e-b1c133018c8d	TCGA.G4.6315	TCGA-G4-6315-D21985	9a8027b9-bdd9-4354-a3df-7c8b335184b3	2012-1-27	FLUOROURACIL	NA	CHEMOTHERAPY	40	FALSE	180	NA	NA	NA	NA	10	NA	MG	MG	672	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	6742	NA
533	ca5b878f-8bff-410a-8e6e-b1c133018c8d	TCGA.G4.6315	TCGA-G4-6315-D21992	fcc343e4-8a19-46af-93e6-fe2c4ef5ad4b	2012-1-27	BEVACIZUMAB	NA	CHEMOTHERAPY	40	FALSE	180	NA	NA	NA	NA	11	NA	MG	MG	298	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	3267	NA
534	ca5b878f-8bff-410a-8e6e-b1c133018c8d	TCGA.G4.6315	TCGA-G4-6315-D21990	ac5b93fb-3aa7-4ff2-8699-5acfe146f59e	2012-1-27	OXALIPLATIN	NA	CHEMOTHERAPY	40	FALSE	138	NA	NA	NA	NA	8	NA	MG	MG	143	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1136	NA
535	cee553c8-460d-436b-b55d-8f41624816cc	TCGA.G4.6317	TCGA-G4-6317-D21907	8a1ce59a-d27d-4bf6-b512-3c41d7ee9704	2012-1-30	OXALIPLATIN	NA	CHEMOTHERAPY	47	FALSE	201	NA	NA	NA	NA	11	NA	MG	MG	170	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1882	NA
536	cee553c8-460d-436b-b55d-8f41624816cc	TCGA.G4.6317	TCGA-G4-6317-D21906	4000a702-021c-48f2-bfa2-e3c52473cf59	2012-1-30	FLUOROURACIL	NA	CHEMOTHERAPY	47	FALSE	201	NA	NA	NA	NA	12	NA	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9664	NA
537	cee553c8-460d-436b-b55d-8f41624816cc	TCGA.G4.6317	TCGA-G4-6317-D21909	f832e4e9-adbc-47e3-8ded-4aa8a47b947b	2012-1-30	LEUCOVORIN	NA	OTHER, SPECIFY IN NOTES	47	FALSE	201	NA	NA	NA	NA	12	ANCILLARY	MG	MG	800	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9600	NA
538	da21e143-dbf6-4ac7-8872-f1d9ae39512d	TCGA.G4.6320	TCGA-G4-6320-D21911	cc241491-1bbe-4a4e-bce5-52b8b63d0f39	2012-1-30	OXALIPLATIN	NA	CHEMOTHERAPY	41	FALSE	145	NA	NA	NA	NA	8	NA	MG	MG	227	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1600	NA
539	da21e143-dbf6-4ac7-8872-f1d9ae39512d	TCGA.G4.6320	TCGA-G4-6320-D21914	2b3677bc-4ef6-4226-ac39-22c5a2c4e2cd	2012-1-30	LEUCOVORIN	NA	CHEMOTHERAPY	41	FALSE	209	NA	NA	NA	NA	12	NA	MG	MG	1068	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	12816	NA
540	da21e143-dbf6-4ac7-8872-f1d9ae39512d	TCGA.G4.6320	TCGA-G4-6320-D21913	536049c4-8854-4618-8702-adba0c21b59c	2012-1-30	FLUOROURACIL	NA	CHEMOTHERAPY	41	FALSE	209	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	400	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4800	NA
541	e7dbfca1-9657-4952-8e0d-dec6373dda5b	TCGA.G4.6321	TCGA-G4-6321-D21919	cdfb2842-633d-48b2-8a2b-47d9c6ffa86e	2012-1-30	LEUCOVORIN	NA	CHEMOTHERAPY	103	FALSE	257	NA	NA	NA	NA	12	NA	MG	MG	824	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9680	NA
542	e7dbfca1-9657-4952-8e0d-dec6373dda5b	TCGA.G4.6321	TCGA-G4-6321-D21918	939cf32b-c067-4fe7-b0d4-5ab549c56393	2012-1-30	FLUOROURACIL	NA	CHEMOTHERAPY	103	FALSE	257	NA	NA	NA	NA	12	NA	MG	MG	824	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	9680	NA
543	e7dbfca1-9657-4952-8e0d-dec6373dda5b	TCGA.G4.6321	TCGA-G4-6321-D21917	2de2d207-7fac-4c6a-b0b3-57c575eff4f3	2012-2-22	OXALIPLATIN	NA	CHEMOTHERAPY	103	FALSE	243	NA	NA	NA	NA	11	NA	MG	MG	175	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1890	NA
544	b3fea9bb-53f9-4ddb-922d-b570562d7a7d	TCGA.G4.6322	TCGA-G4-6322-D21961	609871f8-cee5-4029-bf5c-1f625ca7472f	2012-1-30	OXALIPLATIN	NA	CHEMOTHERAPY	36	FALSE	190	NA	NA	NA	NA	12	NA	MG	MG	180	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	2148	NA
545	b3fea9bb-53f9-4ddb-922d-b570562d7a7d	TCGA.G4.6322	TCGA-G4-6322-D21962	48474a61-d438-4c32-8b45-e077144102f9	2012-1-30	FLUOROURACIL	NA	CHEMOTHERAPY	36	FALSE	190	NA	NA	NA	NA	12	NA	MG	MG	844	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10096	NA
546	b3fea9bb-53f9-4ddb-922d-b570562d7a7d	TCGA.G4.6322	TCGA-G4-6322-D21963	9f9a389b-abde-4403-819f-44e648bcc4b2	2012-1-30	LEUCOVORIN	NA	CHEMOTHERAPY	36	FALSE	190	NA	NA	NA	NA	12	NA	MG	MG	844	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	10096	NA
547	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55540	7EC61416-55CA-4A5A-8732-EAFED12F5DBC	2014-1-8	LEUCOVORIN CALCIUM	NA	ANCILLARY	21	FALSE	189	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
548	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55541	1E720CC7-E366-4CE8-9105-592433C65063	2014-1-8	OXALIPLATIN	NA	CHEMOTHERAPY	21	FALSE	189	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
549	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55542	5DC389D6-7100-4C95-9EEA-2FAEC49C30E9	2014-1-8	BEVACIZUMAB	NA	CHEMOTHERAPY	21	FALSE	266	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
550	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55544	BC6D54D8-A6D1-46EA-B3C9-6672E953FD2D	2014-1-8	FLUOROURACIL	NA	CHEMOTHERAPY	21	FALSE	266	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
551	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55545	BAE5FBCF-0997-4137-9D72-74785EBD0A67	2014-1-8	AVASTIN	NA	IMMUNOTHERAPY	238	FALSE	253	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
552	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55546	82B8C7FF-E00A-425B-8E6C-831795E65E18	2014-1-8	CAPECITABINE	NA	CHEMOTHERAPY	98	FALSE	113	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
553	9D68516E-7E5C-403E-8ACA-EA1ABE0D6014	TCGA.NH.A50U	TCGA-NH-A50U-D55547	AE3FD02D-394D-4F6E-8768-2E54B0E05B02	2014-1-8	REGORAFENIB	NA	CHEMOTHERAPY	280	FALSE	NA	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
554	D3B7ADA6-5395-4212-A921-8E97C92B605D	TCGA.NH.A50V	TCGA-NH-A50V-D40977	86D33EB0-1853-4CA8-9F9A-BF0D9C9B2279	2013-3-8	FLUOROURACIL	NA	CHEMOTHERAPY	22	FALSE	210	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
555	D3B7ADA6-5395-4212-A921-8E97C92B605D	TCGA.NH.A50V	TCGA-NH-A50V-D40978	1543E54E-1A13-4C79-B149-E1B59A6882F6	2013-3-8	OXALIPLATIN	NA	CHEMOTHERAPY	53	FALSE	210	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
556	D3B7ADA6-5395-4212-A921-8E97C92B605D	TCGA.NH.A50V	TCGA-NH-A50V-D67775	16E59916-25D8-47FA-BCB8-D292AF311082	2014-11-11	LEUCOVORIN	NA	ANCILLARY	53	FALSE	210	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
557	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D48254	5EADFF6A-01B3-4724-8D7F-B59A13338091	2013-9-10	OXALIPLATIN	NA	CHEMOTHERAPY	61	FALSE	135	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
558	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D48255	A41B6E53-6845-4700-8105-90A0A05F439F	2013-9-14	AVASTIN	NA	CHEMOTHERAPY	192	FALSE	302	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
559	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D50201	BEFD528B-A161-4395-A63C-4F97439D0540	2013-10-17	AVASTIN	NA	CHEMOTHERAPY	61	FALSE	135	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
560	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D50202	D27B898F-FB23-4CBA-9769-24BAF44B08C2	2013-10-17	LEUCOVORIN	NA	ANCILLARY	192	FALSE	302	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
561	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D58979	0544F341-FD79-42FB-9733-CD6D396CC274	2014-4-29	5-FU	NA	CHEMOTHERAPY	192	FALSE	302	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
562	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D58980	38DFFC3E-A27E-4F6B-BE5E-EBE2884CCC62	2014-4-29	IRINOTECAN	NA	CHEMOTHERAPY	192	FALSE	302	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
563	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D58981	BB7CA757-40E5-485F-B40D-261FA200138F	2014-4-29	LEUCOVORIN	NA	ANCILLARY	61	FALSE	135	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
564	51DCBFAC-6F04-4364-877D-0BF1BD566335	TCGA.NH.A6GA	TCGA-NH-A6GA-D58982	74ED3264-9A64-47E0-8F75-79C3CC3E61DC	2014-4-29	FLUOROURACIL	NA	CHEMOTHERAPY	61	FALSE	135	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
565	E3B0EE77-C419-4B2B-833F-90A221415489	TCGA.NH.A6GB	TCGA-NH-A6GB-D47966	203963D4-D536-4882-BA73-DCE96465215E	2013-9-3	OXALIPLATIN	NA	CHEMOTHERAPY	49	FALSE	212	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
566	E3B0EE77-C419-4B2B-833F-90A221415489	TCGA.NH.A6GB	TCGA-NH-A6GB-D47967	9E5F85B5-470E-4515-8A6D-AE85BC318C71	2013-9-3	BEVACIZUMAB	NA	IMMUNOTHERAPY	49	FALSE	212	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
567	E3B0EE77-C419-4B2B-833F-90A221415489	TCGA.NH.A6GB	TCGA-NH-A6GB-D66874	8642643C-31FB-43C3-A3F7-CBDA20E6E9D8	2014-10-24	LEUCOVORIN	NA	ANCILLARY	49	FALSE	576	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
568	E3B0EE77-C419-4B2B-833F-90A221415489	TCGA.NH.A6GB	TCGA-NH-A6GB-D66875	BEFB19FB-01C4-46FB-AA30-1EC5EAE2D187	2014-10-24	FLUOROURACIL	NA	CHEMOTHERAPY	49	FALSE	576	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
569	0687BEA4-911A-4EF2-9FA2-531EF6BA7910	TCGA.NH.A6GC	TCGA-NH-A6GC-D60511	38D95D8B-82F3-487D-9992-7A0D08960E60	2014-6-10	FLUOROURACIL	NA	CHEMOTHERAPY	186	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
570	0687BEA4-911A-4EF2-9FA2-531EF6BA7910	TCGA.NH.A6GC	TCGA-NH-A6GC-D60512	0FD6191F-0FF6-4426-8563-73D20C9BD713	2014-6-10	OXALIPLATIN	NA	CHEMOTHERAPY	186	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
571	0687BEA4-911A-4EF2-9FA2-531EF6BA7910	TCGA.NH.A6GC	TCGA-NH-A6GC-D60513	072FE925-4152-4D53-82CE-09E9B5CC0652	2014-6-10	BEVACIZUMAB	NA	IMMUNOTHERAPY	186	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
572	6454FF0C-26F8-4CC2-B77C-7E5ABDC20ACD	TCGA.NH.A8F7	TCGA-NH-A8F7-D56709	F230456E-0328-4F0F-95A1-8D60F7CEA832	2014-2-19	FLUOROURACIL	NA	CHEMOTHERAPY	74	FALSE	228	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
573	6454FF0C-26F8-4CC2-B77C-7E5ABDC20ACD	TCGA.NH.A8F7	TCGA-NH-A8F7-D56710	F0209F5E-3A9E-49B9-9A3B-9896B8E2E4C6	2014-2-19	OXALIPLATIN	NA	CHEMOTHERAPY	74	FALSE	228	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
574	6454FF0C-26F8-4CC2-B77C-7E5ABDC20ACD	TCGA.NH.A8F7	TCGA-NH-A8F7-D56711	28D39D44-463B-4B21-A04E-B6C5ABD0A0DD	2014-2-19	BEVACIZUMAB	NA	IMMUNOTHERAPY	74	FALSE	249	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
575	6454FF0C-26F8-4CC2-B77C-7E5ABDC20ACD	TCGA.NH.A8F7	TCGA-NH-A8F7-D67148	DA840463-6BA2-4192-ADCD-5837BB952757	2014-10-31	XELODA	NA	CHEMOTHERAPY	245	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
576	6454FF0C-26F8-4CC2-B77C-7E5ABDC20ACD	TCGA.NH.A8F7	TCGA-NH-A8F7-D67149	F3DB5B7D-5099-444B-B993-6B84A5F90C3A	2014-10-31	BEVACIZUMAB	NA	IMMUNOTHERAPY	334	FALSE	397	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
577	1E0789D6-7EFB-4807-8D36-CD9224675A0C	TCGA.NH.A8F8	TCGA-NH-A8F8-D58585	49ED1A3E-5F7C-4833-B8EC-4A3E03CE86FB	2014-4-15	FLUOROURACIL	NA	CHEMOTHERAPY	49	FALSE	476	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
578	1E0789D6-7EFB-4807-8D36-CD9224675A0C	TCGA.NH.A8F8	TCGA-NH-A8F8-D58586	7642A17D-2740-4D28-A1B8-38B3CD34BF8E	2014-4-15	OXALIPLATIN	NA	CHEMOTHERAPY	49	FALSE	181	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
579	1E0789D6-7EFB-4807-8D36-CD9224675A0C	TCGA.NH.A8F8	TCGA-NH-A8F8-D58588	913BD500-F875-4D0F-A2E7-65FF6CC7FFE6	2014-4-15	BEVACIZUMAB	NA	IMMUNOTHERAPY	76	FALSE	469	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
580	1E0789D6-7EFB-4807-8D36-CD9224675A0C	TCGA.NH.A8F8	TCGA-NH-A8F8-D67094	D595C873-FA75-4453-89C2-319731CC8214	2014-10-30	BEVACIZUMAB	NA	IMMUNOTHERAPY	292	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
581	1E0789D6-7EFB-4807-8D36-CD9224675A0C	TCGA.NH.A8F8	TCGA-NH-A8F8-D67096	3B1F2085-8877-45C8-9B40-3405840006A1	2014-10-30	CAPECITABINE	NA	CHEMOTHERAPY	323	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
582	C83D38FC-E011-4F75-A100-96513611F3E9	TCGA.QG.A5YV	TCGA-QG-A5YV-D44472	90AC2E57-1CE1-40BD-A06A-24E02797C282	2013-6-20	XELODA	NA	CHEMOTHERAPY	72	FALSE	174	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
583	9F45A227-1FD5-478C-A194-4A5C61B68CC3	TCGA.QG.A5YW	TCGA-QG-A5YW-D44480	0D4D2171-F422-48BB-B6AF-7B11900BA704	2013-6-20	CAPECITABINE	NA	CHEMOTHERAPY	42	FALSE	197	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
584	9F45A227-1FD5-478C-A194-4A5C61B68CC3	TCGA.QG.A5YW	TCGA-QG-A5YW-D48503	8B2088DB-6AF0-441E-A2FF-1AD44019549B	2013-9-16	OXALIPLATIN	NA	CHEMOTHERAPY	42	FALSE	197	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
585	300FFF5A-0F61-402D-B845-3938BA7B1294	TCGA.QG.A5YX	TCGA-QG-A5YX-D44483	07AF7F33-432C-43A3-BF5B-12A81384FB74	2013-6-20	XELODA	NA	CHEMOTHERAPY	42	FALSE	527	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
586	9C45EAEC-D854-4F51-80A3-2D80D6B4AEBC	TCGA.QG.A5Z1	TCGA-QG-A5Z1-D44489	807D7DF2-414D-4DA2-9BC6-74DBA0713296	2014-2-17	NA	NA	CHEMOTHERAPY	NA	FALSE	NA	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
587	5F6ED48B-3B5A-4D20-8FBF-C9AA3FEEA186	TCGA.RU.A8FL	TCGA-RU-A8FL-D68261	C47FCF93-73B8-400B-B465-F031923491F1	2014-11-14	C1 FOLFIRI/ZALTRAP	NA	CHEMOTHERAPY	679	FALSE	756	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
588	5F6ED48B-3B5A-4D20-8FBF-C9AA3FEEA186	TCGA.RU.A8FL	TCGA-RU-A8FL-D68258	35B51064-B60A-468F-A98F-BAC6F14F516D	2014-11-14	IRINOTECAN + CETUXIMAB	NA	CHEMOTHERAPY	343	FALSE	677	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
589	5F6ED48B-3B5A-4D20-8FBF-C9AA3FEEA186	TCGA.RU.A8FL	TCGA-RU-A8FL-D68257	09D26C80-A0A1-453B-901C-347775472D0F	2014-11-14	FOLFIRI/AVASTIN	NA	CHEMOTHERAPY	270	FALSE	334	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
590	5F6ED48B-3B5A-4D20-8FBF-C9AA3FEEA186	TCGA.RU.A8FL	TCGA-RU-A8FL-D68088	6F9A2902-54C7-401D-BEEB-5A1F444AFCCE	2014-11-14	FOLFOX	NA	CHEMOTHERAPY	48	FALSE	210	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
591	8D0FA506-3F51-4108-8427-7DABF270BCD4	TCGA.SS.A7HO	TCGA-SS-A7HO-D71978	55A13292-9E26-4AFA-8FCF-9772EE2C47E2	2015-3-31	OXALIPLATIN	NA	CHEMOTHERAPY	37	FALSE	93	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
592	8D0FA506-3F51-4108-8427-7DABF270BCD4	TCGA.SS.A7HO	TCGA-SS-A7HO-D71979	6E855AC1-15F0-41DD-995C-21AA794684C2	2015-3-31	5-FU	NA	CHEMOTHERAPY	37	FALSE	93	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
593	8D0FA506-3F51-4108-8427-7DABF270BCD4	TCGA.SS.A7HO	TCGA-SS-A7HO-D71980	056AC44F-3B85-41FF-9157-7475F0735646	2015-3-31	LEUCOVORIN	NA	ANCILLARY	37	FALSE	93	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
